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Resumo 
 
 
 
Os lantanídeos são substitutos isomórficos dos iões de cálcio, na medida em que possuem 
raios iónicos, preferência pelos átomos doadores e números de coordenação análogos. Devido 
a esta similaridade, estes elementos exibem uma acentuada atividade biológica e têm sido 
investigados devido às suas potenciais aplicações médicas. A afinidade dos lantanídeos pelo 
tecido ósseo já é reconhecida há décadas, contudo, só recentemente foi sugerido o seu poten-
cial para substituir o cálcio ósseo e afetar o ciclo de remodelação óssea, através da modelação 
do desenvolvimento das células ósseas. O efeito dos lantanídeos em populações celulares rele-
vantes para o metabolismo ósseo têm sido analisado em diversos trabalhos. Contudo, apenas 
um número limitado de trabalhos reportou o efeito destes elementos em células ósseas huma-
nas cultivadas in vitro.  
Neste contexto, analisaram-se os efeitos celulares e moleculares dos lantanídeos no desen-
volvimento de células humanas precursoras de osteoblastos e osteoclastos. As culturas celulares 
de osteoblastos foram obtidas a partir de cabeças de fémur de pacientes (25-45 anos) subme-
tidos a cirurgia ortopédica e foram caracterizadas para o conteúdo de ADN, apoptose, atividade 
da fosfatase alcalina (ALP), coloração histoquímica da ALP e colagénio, e coloração da F-actina. 
As culturas celulares de osteoclastos foram estabelecidas a partir de células percursoras isola-
das de sangue periférico humano (PBMCs) e caracterizadas para o conteúdo de ADN, apoptose, 
atividade da fosfatase ácida resistente ao tartarato (TRAP), número de células multinucleadas 
TRAP positivas e pela presença de células com anéis de actina e que expressam recetores de 
vitronectina e calcitonina. Adicionalmente, foi também analisado o envolvimento de algumas 
vias de sinalização associadas ao processo de osteoblastogénese e osteoclastogénese, na res-
posta celular induzida pelos lantanídeos.  
As culturas celulares estudadas foram cultivadas na presença de zinco e magnésio (como 
catiões de referência) e três lantanídeos diferentes (cério, lantânio e praseodímio) em concen-
trações compreendidas entre 10-7 e 10-3 M e foram caracterizadas após 14 e 21 dias em cultura. 
 Os resultados obtidos indicaram que o cério (na maioria das concentrações testadas) não 
afetou significativamente a proliferação dos precursores osteoblásticos. Adicionalmente, foi 
observado que este catião, nas concentrações mais baixas testadas, induziu a diferenciação dos 
precursores osteoblásticos e que este efeito foi perdido nas concentrações mais altas testadas. 
A densidade dos precursores osteoclásticos foi regulada positivamente pelas concentrações 
mais baixas de lantânio, contudo, este efeito foi-se perdendo ao longo do tempo. Por outro 
lado, a diferenciação dos precursores osteoclásticos foi inibida pelas concentrações mais altas 
de lantânio em ambos os dias.  
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O praseodímio, independentemente da concentração testada, pareceu actuar como um mo-
dulador positivo da proliferação dos precursores osteoblásticos, enquanto a influência oposta 
foi observada relativamente à densidade dos precursores osteoclásticos. Embora este catião 
tenha mostrado a capacidade de regular negativamente a diferenciação tanto dos precursores 
osteoblásticos como dos precursores osteoclásticos, nas culturas dos precursores osteoclásticos 
este efeito só foi observado nas concentrações mais altas. 
Todos os lantanídeos testados modularam o desenvolvimento das células osteoclásticas e 
osteoblásticas, embora tenham revelado diferentes perfis de modulação dos processos de os-
teoblastogénese e osteoclastogénese. Adicionalmente, foi observado que o efeito promovido 
pelos lantanídeos depende da sua concentração e do tempo de cultura. Foi ainda observado 
que o mesmo lantanídeo pode afetar os dois tipos celulares de forma inversa. Em termos gerais 
as vias de sinalização testadas foram afetadas de forma diferente pelos lantanídeos, sugerindo 
que estes elementos afetam os processos de osteoblastogénese e osteoclastogénese através de 
diferentes mecanismos. 
Em suma, este trabalho demonstrou a capacidade dos lantanídeos de modular o desenvol-
vimento de células ósseas humanas e estabeleceu algumas das vias de sinalização que poderão 
estar envolvidas na resposta celular induzida pelos mesmos. Os resultados obtidos reiteraram a 
necessidade de compreender e manipular o comportamento dual destes elementos de forma a 
induzir o efeito pretendido. Deste modo, é necessário investigar com mais detalhe o efeito dos 
lantanídeos na atividade das células ósseas humanas e clarificar os seus mecanismos de ação. 
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Abstract 
 
 
 
Lanthanides are isomorphic replacements of calcium ions, as they possess analogous ionic 
radius, donor atom preferences and coordination numbers. By virtue of their resemblance to 
calcium, lanthanides exhibit a pronounced biological activity and have attracted intensive re-
search interest for medical applications. Although the affinity of lanthanides for bone has been 
known for decades, their potential to exchange with calcium in bone and affect bone remod-
eling cycle, by modulating osteoblast and osteoclast development, was only suggested a few 
years ago. Since then, several works have addressed the effect of lanthanides in cellular popu-
lations with relevance to bone metabolism. Nevertheless, only a limited number of studies have 
reported the effect of lanthanides on human bone cells cultured in vitro. Furthermore, the 
signaling pathways involved on the cellular response have not yet been elucidated. 
In this context, the aim of this study was to investigate the cellular and molecular effects 
of lanthanides on human osteoblast and osteoclast precursor cells development. Osteoblast 
precursor cell cultures were obtained from femur heads of patients (25-45 years old) undergoing 
orthopedic surgery procedures and were then studied for DNA content, apoptosis, alkaline phos-
phatase (ALP) activity, histochemical staining of ALP and collagen, and F-actin staining. Oste-
oclastic cell cultures were established from precursor cells isolated from human peripheral 
blood (PBMCs) and were characterized for DNA content, apoptosis, tartrate-resistant acid phos-
phatase (TRAP) activity, number of TRAP-positive multinucleated cells, and the presence of 
cells displaying F-actin rings and expressing vitronectin and calcitonin receptors. Also the in-
volvement of some osteoblastogenesis and osteoclastogenesis-related signaling pathways on 
cellular response were addressed. 
Cell cultures were treated with zinc, magnesium (as reference physiological cations) and 
three different lanthanides (cerium, lanthanum and praseodymium) at concentrations of 10-7 M 
to 10-3 M, and were characterized at days 14 and 21. 
The results showed that cerium (in the majority of the concentrations tested) was not able 
to significantly affect the proliferation of osteoblast precursor cells. Moreover, it was observed 
that this cation induced the differentiation of osteoblast precursor cells at the lowest concen-
trations tested, and that this effect was lost at the highest concentrations. 
The density of osteoclast precursor cells was up-regulated by the lowest concentrations of 
lanthanum, nevertheless, this effect was also showed to be lost over time. On the other hand, 
the differentiation of osteoclast precursor cells was inhibited by the highest concentrations of 
lanthanum at both days. 
v 
Praseodymium, regardless of the concentration tested, appeared to act as a positive mod-
ulator of osteoblast precursor cells proliferation, while the opposite influence was observed 
concerning the density of osteoclast precursor cells. Although, this cation was shown to be able 
to regulate negatively the differentiation of both osteoblast and osteoclast precursor cells, this 
effect on osteoclast cultures was only observed at the highest concentrations tested. 
Hence, all lanthanides were shown to be able to affect osteoclastic and osteoblastic pre-
cursor cells development although with different profiles on their osteoblastogenic and osteo-
clastogenic modulation properties. Moreover, it was observed that the effect of the lanthanides 
is closely related to the concentration and culture time. Also, it was observed that the same 
lanthanide may affect osteoclastic and osteoblastic precursor cells development in an antago-
nistic manner.  
The signaling pathways involved in the process were overall affected differently by the 
different lanthanides tested, suggesting that they affect osteoblastogenesis and osteoclasto-
genesis processes through different mechanisms. 
In sum, the present study underlined the ability of lanthanides to modulate the develop-
ment of human bone cells and outlined some of the signaling pathways involved in this cellular 
response. Furthermore, the results obtained reiterate the need to understand and to manipu-
late the dual behavior of these elements to attain the required effect. Accordingly, further 
experiments are required to fully understand the effect of lanthanides on human bone cells 
activity and their mechanism of action.  
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Chapter 1 
 
 
General Introduction 
 
 
 
1.1 Bone Tissue  
 
Bone is a dynamic and specialized connective tissue, with a unique capacity to heal and 
remodel without leaving a scar (Salgado, Coutinho, & Reis, 2004). One of the primary functions 
of this tissue is to provide the mechanical integrity for both locomotion and protection of the 
vital organs. Metabolically, bone maintains the mineral homeostasis, regulates the acid-base 
balance, acts as a reservoir of growth factors and cytokines, and stores energy reserves as lipids 
in areas filled with yellow bone marrow. Furthermore, bone tissue encloses the red bone mar-
row thus providing the environment for haematopoiesis to occur (Kini & Nandeesh, 2012). 
This tissue is renewed continuously in the adult skeleton in response to a variety of stimuli 
by the process of bone remodelling (Datta, Ng, Walker, Tuck, & Varanasi, 2008). This process 
allows each bone to adapt to changes in biomechanical forces and guarantees the removal of 
old and microdamaged bone, replacing it with new and mechanically stronger bone which en-
sures the preservation of bone strength (Clarke, 2008). Bone remodelling involves the interac-
tion between different cell phenotypes and is regulated by a variety of biochemical and me-
chanical factors (Hadjidakis & Androulakis, 2006). A disruption or imbalance in these processes 
can lead to either an increase or decrease in bone mineral density that may be detrimental to 
skeletal strength. Accordingly, the process of bone turnover must be carefully regulated in 
order to maintain bone strength  (Datta et al., 2008). 
 
 
1.2 Macroscopic Morphology 
 
On a macroscopic level, bone exists in one of two forms: cortical bone, also called dense 
or compact bone, and trabecular bone, also called cancellous or spongy bone (Bancroft & Mikos, 
2002; Sandhu, 2003). Overall the adult human skeleton is constituted of 80% cortical bone and 
20% trabecular bone (Buckwalter, Glimcher, Cooper, & Recker, 1995; Hadjidakis & Androulakis, 
2006). However, different types of bone and skeletal sites within the bone present different 
ratios of cortical to trabecular bone. For example, the ratio of cortical to trabecular bone in 
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the vertebra is 25 to 75 percent, in the femoral head 50 to 50 percent and 95 to 5 percent in 
the radial diaphysis (Clarke, 2008). 
Cortical bone presents two types of surfaces. The surface on its inner side, facing the bone 
marrow, is known as the endosteum, and the surface facing the surrounding soft tissues, is 
known as the periosteum (Morgan, Barnes, & Einhorn, 2010). Cortical bone is dense and orga-
nized, providing protection and mechanical support. It is only 10% porous, and therefore pro-
vides space for only a low concentration of cells and blood vessels (Suárez-González & Murphy, 
2008).This tissue makes up the outer tubular shell of long bones and the outer surface of small 
and flat bones in the skeleton (Bancroft & Mikos, 2002). 
Trabecular bone is loosely organized and highly porous (50-90% porosity) and contains a 
functional vasculature and a bone marrow space (Suárez-González & Murphy, 2008). Due to its 
characteristics, trabecular bone is more elastic, has a higher turnover rate and performs a more 
active metabolic function than cortical bone (Downey & Siegel, 2006). Trabecular bone is found 
near the ends of long bones, in the interior of small bones, and between the surfaces of flat 
bones (Bancroft & Mikos, 2002). 
 
 
1.3 Microscopic Morphology  
 
At the microscopic level, bone is described as either woven or lamellar bone, depending on 
the organization of the collagen fibres (Becken, Hilger, & A.E., 2005).  
Woven bone, also designated as primary bone, is characterized by a random organization 
of the collagen fibres. This type of bone exists mainly during embryonic and fetal development. 
In later years, woven bone is found at sites of fracture healing and in some metaphyseal regions 
of the growing skeleton since it is laid down more quickly than lamellar bone (Downey & Siegel, 
2006; Kini & Nandeesh, 2012; Morgan et al., 2010). Lamellar bone, which is the major portion 
of both cortical and trabecular bone in adults, is more highly organized and specialized than 
woven bone. Collagen fibres in the lamellar bone are aligned in thin sheets, called lamellae, 
which are stacked in a plywood-type arrangement (Morgan et al., 2010).  
Both woven and lamellar bones contain small cavities called lacunae which are connected 
to each other by means of tubular canals called canaliculi. The lacunae are arranged along the 
interfaces between the lamellae in the lamellar bone. Osteocytes, a specific type of bone cells, 
remain entrapped within these lacunae and receive and transmit nutrients and stimuli from and 
to the bone through the canaliculi (Cowin, 2007; Kamioka, Honjo, & Takano-Yamamoto, 2001). 
Lamellar bone is also commonly arranged in smaller cylindrical structures, called secondary 
osteons or Harversian systems (Gore, Unnikrishnan, Hussein, & Morgan, 2012). Osteons make 
up approximately two-thirds of cortical bone volume. Each osteon consists of 10 to 30 concen-
tric rings of lamellae, which surround a central cavity, the Haversian canal, in which blood 
vessels and nerves are contained. Each osteon is in direct contact with the periosteum, the 
bone marrow and with other osteons through horizontally oriented canals, called Volkmann’s 
canals. The osteons have a typical diameter of approximately 200 µm and lengths of 1 to 3 mm. 
The outer border of each osteons contains a cement line that consists of a layer of mineralized 
matrix attaching adjacent osteons together (Gore et al., 2012; Morgan et al., 2010). 
In trabecular bone, the counterpart to the osteon is the trabecular packet (Sandhu, 2003). 
Although, trabeculae are primarily composed of lamellar bone arranged in packets, ticker tra-
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beculae can also contain secondary osteons (Gore et al., 2012). Trabecular osteons are semilu-
nar in shape, normally approximately 35 mm thick, and composed of concentric lamellae. It is 
estimated that there are 14 x 106 trabecular osteons in healthy human adults, with a total 
trabecular area of approximately 7 m2 (Clarke, 2008). 
 
 
1.4 Microscopic Organization 
 
Bone is a composite material containing an inorganic and an organic phase. By weight, 
approximately 60% of bone tissue is inorganic matter, 8 to 10% water and the remainder, is 
organic matter (Gong, Arnold, & Cohn, 2005). 
The mineral (or inorganic) phase of bone is mainly formed by a calcium-deficient, car-
bonate-containing, poorly-crystalline analogue of the naturally occurring mineral hydroxyap-
atite (Ca10(PO4)6(OH)2 or HAp) (A.L. Boskey, 2005). The small plate-shaped (20-50 mm long, 15 
nm wide, and 2-5 nm thick) apatite crystals contain impurities, most notably small amounts of 
carbonate in place of the phosphate groups. Other noticed substitutions are magnesium, potas-
sium, strontium and sodium in place of the calcium ions and chloride and fluoride in place of 
the hydroxyl groups. These impurities reduce the crystallinity of the apatite resulting in the 
change of certain physical properties, such as the solubility (Zhu, Robey, & Boskey, 2010). 
Hence, bone mineral crystals are more soluble than geologic apatite, which facilitates bone to 
act as a reservoir for calcium and phosphate and other ions (Hammett-Stabler, 2004).  
The organic matrix (or osteoid) is mainly composed of type I collagen that constitutes up to 
85-90% of the total protein in the bone matrix. The remaining 10-15% in composed of noncolla-
genous proteins, whereas the cellular content comprises less than 1% of the bone mass (Robey 
& Boskey, 2008). Type I collagen is the most abundant protein in vertebrates. Besides being 
expressed in bone, type I collagen is also expressed in most of the other connective tissues, 
especially in tendons, ligaments and dermis. The repetitive nature of the amino acid sequences 
of collagen, which consists of Gly-X-Y, where X and Y are often proline and hydroxyproline 
residues, allows the protein to assemble into triple helical structures. Type I collagen is se-
creted as a propeptide, but the globular ends are cleaved rapidly by specific proteases, in order 
that shorter molecules assemble to form fibrils (Bou-Gharios & Crombrugghe, 2008). These fi-
brils are gathered in bundles to form collagen fibres. Noncollagenous proteins and mineral are 
found within gaps, named hole zones, that exists at the ends of collagen molecules and within 
pores formed between the sides of parallel molecules (Gore et al., 2012; Morgan et al., 2010).  
Noncollagenous proteins present in bone matrix appear to regulate the organization, turn-
over, and mineralization of the bone matrix. In fact, most of these proteins appear to have 
more than one function (A.L. Boskey, 2005).  
Osteocalcin (OC) is the major non-collagenous protein of bone, accounting for 10 to 20% of 
the noncollagenous protein content (van Gaalen et al., 2008). OC is exclusively synthesized by 
osteoblasts, odontoblasts, and hypertrophic chondrocytes and is only marginally detectable 
during the earlier phases of proliferation and matrix maturation (Seibel, 2001). This protein 
contains three vitamin-K dependent gamma-carboxyglutamic acid (Gla) residues, which are re-
sponsible for the calcium-binding properties (van Leeuwen, van der Eerden, van de Peppel, 
Stein, & Lian, 2013). Due to its interaction with HAp it is believed that OC regulates the growth 
and maturation of bone crystals (Gundberg, 2003). Moreover, some investigators have suggested 
that OC may act as a chemoattractant for osteoblasts (Chenu et al., 1994). 
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Osteonectin, osteopontin and bone sialoprotein are multifunctional phosphorylated glyco-
proteins with high affinity for bone mineral carrying one or more arginine-glycine-aspartate 
(RGD) sequences, thus capable to linking cells, mineral and matrix (A.L. Boskey, 2005). Oste-
onectin (ON) is a glycoprotein secreted by the osteoblast that binds collagen, calcium and Hap 
(van Leeuwen et al., 2013). It is assumed that this molecule supports bone remodelling, regu-
lates cell proliferation and cell-matrix interactions, and stimulates the production of matrix 
metalloproteinases (Sroga & Vashishth, 2012). Osteopontin (OPN) is a phosphorylated glycopro-
tein that is expressed in several tissues, including bone, kidney and in the immune and vascular 
systems (Lund, Giachelli, & Scatena, 2009). In bone, OPN is produced by osteoblasts, osteocytes, 
macrophages, and osteoclasts and is found at the late stage of osteoblastic maturation, during 
matrix formation and mineralization (Robey, 2008; Zhu et al., 2010).OPN promotes osteoclast 
binding to the extracellular matrix and activates intracellular signalling pathways  (McNamara, 
2011; Robey, 2008). During normal bone mineralization, osteoclast‐derived OPN inhibits the 
formation of HAp, thus acting as an inhibitor of mineralization (Hunter, 2013). Bone sialoprotein 
(BSP) comprises 15% of the total noncollagenous proteins in bone (Wuttke et al., 2001). BSP 
expression marks a late stage of osteoblastic differentiation and an early stage of matrix min-
eralization (Robey, 2008). This sialoprotein binds to collagen and promotes osteoblast attach-
ment (A.L. Boskey, 2005). Additionally, it is considered that BSP also plays a role in matrix 
mineralization due to its high affinity for calcium and because of the timing of its appearance 
in relation to the timing of mineral emergence (Robey, 2008). Although, alkaline phosphatase 
(ALP) is found mainly distributed on the cell membrane and in matrix vesicles, it is also a bone 
matrix constituent (Bonucci, 2013).  ALP is considered an important regulator of mineralization, 
due to its ability to enzymatically degrade pyrophosphate, a mineralization inhibitor (Gade et 
al., 2011).  
Proteoglycans play important roles in organizing the bone extracellular matrix, taking part 
in the structuring of the tissue itself as active regulators of collagen fibrillogenesis (Lamoureux, 
Baud'huin, Duplomb, Heymann, & Rédini, 2007). The two most abundant proteoglycans present 
in bone matrix are decorin, and biglycan (Zhu et al., 2010). These proteoglycans bind to type I 
collagen and interact with several growth factors, therefore, it is assumed that they play a part 
in modulating the activity of growth factors and matrix proteins (Robey, 2002). Furthermore, 
decorin and biglycan were both found to inhibit bone cell attachment, apparently by binding 
to fibronectin and inhibiting its cell-matrix binding abilities (Robey, 2002).  
Growth factors and cytokines such as, transforming growth factor-β (TGF-β), insulin-like 
growth factor (IGF), osteoprotegerin, tumour necrosis factors (TNFs), interferon-γ and bone 
morphogenetic proteins (BMPs 2-10) are present in very small quantities in bone matrix. These 
proteins are responsible for the regulation of bone cell behaviour, namely for, cell differentia-
tion, activation, growth and turnover. Additionally, it is thought that these growth factors act 
as coupling factors linking bone resorption and formation processes (Zhu et al., 2010).  
 
1.4.1 Matrix Mineralization 
Mineralization of bone collagen fibrils occurs in an organized manner. Initially crystal ap-
pear in hole zone regions within individual fibrils, separated by unmineralized regions. Gradu-
ally they start to appear in an increasing number of hole zone regions. Ultimately, crystal 
growth, embraces the zone of the collagen fibrils between hole zones and occupies all of the 
available space within the fibrils (Buckwalter et al., 1995).  
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One possible mechanism of HAp crystal formation is via extracellular matrix vesicles (MVs) 
(New & Aikawa, 2013). MVs are small (approximately 100 nm in diameter) membrane particles, 
which bud off from the plasma membrane of mineralizing cells (chondrocytes, osteoblasts and 
odontoblasts) and are released into the pre-mineralized organic matrix (Golub, 2011; Vigorita, 
2008). The signals that promote MVs release are not well understood, although concentrations 
of intracellular calcium and extracellular phosphate may be important (Orimo, 2010).  
Mineralization occurs in two phases: an initial formation of apatite within the MV, and a 
subsequent propagation phase in the matrix (Golub, 2011). The first phase starts with the in-
corporation of calcium into the MV by calcium-binding proteins and calcium-binding lipids pre-
sent in the MV membrane. Phosphate concentration is also raised during this phase through the 
enzymatic activity of phosphohydrolases, such as ALP, which reside on the MV membrane (An-
derson, 2003; Leonor, Azevedo, Alves, & Reis, 2005; Nair & Jagannathan, 2013). At some point, 
the elevation of calcium and phosphate within the protective environment of the membrane 
leads to the precipitation of amorphous calcium phosphate mineral.  The amorphous calcium 
phosphate mineral is later converted into HAp via octacalcium phosphate. Subsequently, HAp 
crystals penetrate the MV membrane and get exposed to the extracellular fluid leading to the 
beginning of the second phase of mineralization process. The breakdown of MVs is assisted by 
the hydrolytic action of phospholipases and proteases (Anderson, 2003; Nair & Jagannathan, 
2013). During the second phase the preformed apatite from the MVs migrate to collagen, be-
come inserted into the aligned hole zones of the fibrils, and then undergo maturation (Golub, 
2011; Leonor et al., 2005). Rates of mineralization are affected by levels of calcium and phos-
phate in the extracellular fluid, pH, and by matrix components that are able to accelerate or 
retard mineral propagation (Vigorita, 2008). 
Several families of proteins associated with the collagen matrix are involved in regulation 
of the mineralization process, as both inhibitors and promoters of mineralization depending on 
the extent of post-translational modification and/or their concentration (A.L Boskey, 2007). 
BSP, ON, dentin sialophosphoprotein, and ALP are nucleators or initiators of mineral crystal 
formation. These proteins bind to calcium and/or phosphate ions, creating a surface similar to 
the apatite surface that provides the start of nucleation (Clarke, 2008; Zhu et al., 2010). Pro-
teins, such as aggrecan, OPN, dentin matrix protein-1, α2-HS glycoprotein, and albumin act as 
inhibitors of mineral crystal formation. These proteins can chelate calcium or phosphate ions 
creating a protected environment around the crystal nucleus which prevents crystal growth. 
On the other and OC, vitronectin and matrix Gla protein bind to one or more faces of the 
growing crystal, blocking crystal growth in one or more directions or blocking growth beyond a 
specific size. Other proteins, such as decorin, thrombospondin, fibronectin, vitronectin and 
versican bind to the collagen backbone of the matrix and to other non-collagenous proteins, 
changing their conformation and their ability to affect crystal nucleation and growth  (Zhu et 
al., 2010). Vitamin D participates indirectly in the promotion of bone matrix mineralization. 
Calcitriol, of the active form of vitamin D, maintains the appropriate serum calcium and phos-
phorus concentrations required for passive mineralization, through the stimulation of intestinal 
absorption of these minerals (Clarke, 2008). 
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1.5 Bone Cells 
 
The main cell types associated with bone homeostasis are osteocytes, osteoclasts and os-
teoblasts. These cells account for approximately 90% of all cells in the adult skeleton (Morgan 
et al., 2010; Sommerfeldt & Rubin, 2001). Bone cells are originated from two particular cell 
lines lineages: a mesenchymal stem cell lineage and a hematopoietic stem cell lineage. The 
osteoblasts and osteocytes are derived from mesenchymal stem cells (MSCs), whereas preoste-
oclasts and osteoclasts are originated from hematopoietic stem cells (Buckwalter et al., 1995; 
Downey & Siegel, 2006). 
 
1.5.1 Osteoblasts 
Osteoblasts are the cells responsible for the synthesis and mineralization of osteoid, the 
protein component of bone tissue. Moreover, osteoblasts are also involved in the regulation of 
osteoclast differentiation and activity (Ferrari et al., 2000; Kini & Nandeesh, 2012).  
As mentioned formerly, osteoblasts derive from pluripotent MSCs, which prior to osteoblast 
commitment can also differentiate into fibroblasts, chondrocytes, myoblasts and bone marrow 
stromal cells depending on the activated signalling transcription pathways (A. Yamaguchi, 
Komori, & Suda, 2000b). 
Osteoblasts are cuboidal cells, usually found in a single layer adherent to bone surface and 
contain an extensive and oriented secretory organelle apparatus that includes a large Golgi 
complex near the nucleus, a well-developed rough endoplasmatic reticulum and a high mito-
chondrial content (Kartsogiannis & Wah Nga, 2004; Mackie, 2003). 
The maintenance of osteoblastic function and the ability of these cells to respond to met-
abolic and mechanical stimuli is sustained by cell-matrix and cell-cell interactions that occur 
through a variety of transmembranous proteins, such as, integrins, conexins and cadherins and 
specific receptors for cytokines, hormones and growth factors. In addition, the tight junctions 
formed between adjacent osteoblasts have regions of the plasma membrane specialized in ve-
sicular trafficking and secretion (Ferrari et al., 2000; Sommerfeldt & Rubin, 2001). 
As osteoblasts differentiate from their precursors they begin to secrete bone matrix pro-
teins into the region of unmineralized matrix between the cell body and the mineralized matrix 
(Gay, Gilman, & Sugiyama, 2000). The lifespan of human osteoblasts it is of approximately 8 
weeks, and during this period osteoblasts lay down 0.5 to 1.5 μm of osteoid per day (Sommer-
feldt & Rubin, 2001). 
As mentioned, besides their role in osteoid synthesis, osteoblasts are also involved in oste-
oid mineralization. As osteoid becomes mineralized, osteoblasts follow one of three pathways: 
persist as active osteoblasts and disappear from the site of bone formation; become surrounded 
by their own calcified matrix and change their phenotype turning into osteocytes or become 
fairly inactive, decrease their synthetic activity and assume a flatter shape of bone lining cells 
(Dallas & Bonewald, 2010). 
 
1.5.1.1 Osteoblastogenesis 
Osteoblastogenesis can be divided into three stages, namely proliferation, matrix develop-
ment, and maturation and mineralization  (Eglence, Duivenvoorden, Ghert, & Singh, 2009). In 
the first stage, cells proliferate intensively and produce some extracellular matrix proteins, 
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such as fibronectin and type I collagen (Przekora & Ginalska, 2015). The second stage is char-
acterized by a modification in the composition of extracellular matrix, a downregulation of 
proliferation and activation of genes correlated with matrix maturation and organization (Le-
onor, Gomes, Bessa, Mano, & Reis, 2008). The third stage of differentiation is connected with 
the mineralization process. During this stage osteoblasts have moderate ALP activity, high min-
eralization activity and express high levels of proteins that are correlated with mineral deposi-
tion (mainly, OPN and OC) (Przekora & Ginalska, 2015). 
The markers most frequently used to follow osteoblasts differentiation include type I col-
lagen, ALP and OC. Overall, type I collagen and ALP are thought as early osteoblastogenesis 
markers, while, OC is considered an advanced marker of osteoblast differentiation due to it’s 
closely association with bone matrix mineralization (Eglence et al., 2009). 
Two transcription factors have been demonstrated to be required for osteoblast formation 
and differentiation, namely, runt-related transcription factor 2 (Runx2) and Osterix (Osx).  
Runx2 has been described as a master regulator of osteoblastogenesis (Baek, Choi, & Kim, 
2014). Expression of Runx2 is both necessary and sufficient for MSC differentiation towards the 
osteoblastic lineage. This factor directly stimulates the transcription of osteoblast-related 
genes, such as those encoding TGF-β receptor, ALP, OC, OPN, vitamin D receptor, BSP, type I 
collagen and collagenase, by binding to specific enhancer regions containing the core sequence 
(Mackie, 2003). Hence, Runx2-deficient mice exhibit a complete lack of both intramembranous 
and endochondral ossification due to the absence of osteoblast differentiation (Baek et al., 
2014). Runx2 can be phosphorylated and thus activated by the mitogen-activated protein kinase 
(MAPK) cascade via stimulation of α2β1-integrins on the osteoblast surface. Both expression 
and activity of Runx2 are tightly controlled by other transcription factors and by protein–DNA 
or protein–protein interactions. Stat1, Sox9, Sox8, Aj18, MEF, Nrf2, and YAP have been reported 
to repress Runx2 expression, while, Rb, TAZ, HoxA10, BAPX-1, Smad1&5, CEBP/β&δ, and Menin 
actively enhance the function of Runx2 (J.F.L.  Chau, Leong, & Li, 2008). 
The second required transcription factor for osteoblast differentiation is the zinc finger-
containing transcription factor Osx (J.F.L. Chau, Leong, & Li, 2009). It has been demonstrated 
that Osx is necessary for bone formation and mineralization in vivo (Nakashima et al., 2002). 
Genetic inactivation of Osx in mice results in completely lack of mineralized bone (Baek et al., 
2014). 
Additional studies indicated that Osx acts downstream of Runx2 in the transcriptional cas-
cade of osteoblast differentiation since Osx knock-out mice express Runx2, but Osx is not ex-
pressed in Runx2 knock-out mice (Baek et al., 2014; C. Zhang  et al., 2011). The mechanism 
underlying the regulation of Osx expression in osteoblasts is still unclear. However, it was shown 
that both BMP-2 and IGF-1 can induce Osx expression in undifferentiated MSCs. Furthermore, 
ascorbic acid and 1,25(OH)2 vitamin D3, have also been shown to up-regulate Osx expression. 
On the other hand, some studies emphasized the ability of negative regulators of osteoblasto-
genesis to inhibit Osx expression. For instance, TNF was demonstrated to inhibit Osx mRNA in 
pre-osteoblastic cells (C. Zhang 2010). 
BMP, Wnt, and Notch signalling pathways play important roles in osteoblast differentiation 
(Lin & Hankenson, 2011).  
The first indication that Wnt signalling plays a critical role in bone formation came from 
human genetic studies where recessive loss-of-function mutations in lipoprotein receptor-re-
lated protein (LRP) 5  were linked to osteoporosis, while, dominant missense LRP5 mutations 
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were associated with high bone mass diseases (Lin & Hankenson, 2011; Zuo et al., 2012). Ca-
nonical Wnt signalling in osteoblastogenesis has been linked to Runx2. The Runx2 gene promoter 
contains a Wnt-responsive T-cell factor (Tcf) regulatory element, and both β-catenin and Tcf1 
are recruited to the Runx2 locus. Additionally, transient activation of Wnt/β-catenin signalling 
in MSCs in vitro induces expression of bone lineage genes such as Distal-less homeobox-5 (Dlx5) 
and Osx (Lin & Hankenson, 2011). 
In vitro and in vivo studies have established that BMP-Smad signalling regulates osteoblast 
differentiation from MSC, osteoprogenitor cell expansion, osteoblast bone formation activity, 
and its coupling to osteoclasts (J.F.L. Chau et al., 2009). BMP2 activates Smad1/5/8 signalling 
and regulates the transcription of osteogenic genes, including Dlx5, which is a key mediator of 
BMP2-induced expression of Runx2 (Jang, Kim, Lee, Son, & Koh, 2011). In vitro studies with a 
human marrow stroma derived cell line, demonstrated that BMP2 treatment promotes the in-
crease of both Runx2 gene expression and ALP levels (Gori, Thomas, Hicok, Spelsberg, & Riggs, 
1999).  
MAPKs, namely, the p38, extracellular signal-regulated kinase (ERK) 1/2 and c-Jun N-ter-
minal kinase (JNK) 1/2  were shown to promote the expression and activation of Runx2 (R. L. 
Huang, Yuan, Tu, Zou, & Li, 2014). Additionaly, the inhibition of p38 MAPK was shown to down-
regulate Osx expression and reduce osteoblast differentiation (J.F.L.  Chau et al., 2008). 
As with BMP and Wnt signalling in osteogenesis, Runx2 function is also influenced by Notch 
signalling. Runx2 transcriptional activity is physically antagonized by the protein encoded by 
Notch target gene Hey1 (Lin & Hankenson, 2011). Transient transfection of MSCs with Notch 
intracellular domain, Hey decreases Runx2 transactivity. In addition, Notch intracellular do-
main can interact directly with Runx2 protein and repress terminal osteoblastic differentiation 
in vitro (Lin & Hankenson, 2011). 
In addition, several hormones, such as, IGF-1, parathyroid hormone (PTH), and glucocorti-
coids influence osteoblast differentiation. For instance, PTH has been found to regulate the 
expression and activity of Runx2 and to inhibit Osx expression (Barbuto & Mitchell, 2013). More-
over, IGF-1 has been shown to promote osteoblast differentiation and mineralization in vitro 
(W. Zhang et al., 2012). Lastly, glucocorticoid have been shown to inhibit osteoblast differen-
tiation through the suppression of cytokines such as interleukin (IL)-11 (Rauch et al., 2010). 
 
1.5.2 Osteoclasts 
Osteoclasts are highly specialized, multinucleated and terminally differentiated cells gen-
erally regarded as the only cells in the body capable of resorbing bone (Chambers, 2000; Clarke, 
2008; Itzstein, Coxon, & Rogers, 2011). 
 Mobilization of osteoclasts precursors involves their release from bone marrow to the blood 
circulation and their guidance to bone resorption sites, where these cells fuse into multinucle-
ated cells to form mature osteoclasts, a process that is regulated by osteoblasts and stromal 
cells of the bone marrow (Boyle, Simonet, & Lacey, 2003; Soysa, Alles, Aoki, & Ohya, 2012) 
Osteoclasts contain large numbers of mitochondria and acidic vacuoles that carry acid phos-
phatases and other lysosomal enzymes. Compared to the cytoplasmic volume of the cells, the 
rough endoplasmic reticulum is scarce and the Golgi apparatus consists of few flattened cister-
nae around the nuclei, suggesting that mature osteoclasts do not synthesise large amounts of 
protein (Stenbeck, 2002). 
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Bone resorbing cells are highly migratory cells with a relatively short lifespan and consid-
ered rare in bone with only two to three cell per mm (Miyazaki et al., 2012). Activated osteo-
clasts are able to resorb 200000 µm3 of bone per day, an amount of bone formed by seven to 
ten generations of osteoblasts (Sommerfeldt & Rubin, 2001).  
 
1.5.2.1 Osteoclast Activity 
Osteoclast activation is initiated upon cell attachment to bone matrix, an event leading to 
osteoclast actin cytoskeletal reorganization. Cytoskeletal organization promote osteoclast po-
larization and the formation of new membrane domains, namely, the sealing zones and the 
ruffled membrane (Bellido, Plotkin, & Bruzzaniti, 2014). 
The sealing zone appears as a ring of filamentous actin (F-actin, known as the actin ring), 
consisting of dynamic, densely packed small actin punctuate structures, called podosomes. 
These consist of a core of densely packed actin filaments and F-actin-associated proteins such 
as cortactin, Wiskott-Aldrich syndrome protein (WASp) and actin-related proteins (Arp) 2/3, 
surrounded by integrins and attachment-related proteins such as vinculin and talin (Itzstein et 
al., 2011). 
The attachment of osteoclast to bone matrix is controlled by the vitronectin receptor, αvβ3 
receptor, which binds to RGD sequences within matrix proteins, such as vitronectin, OPN, and 
type I collagen (Bellido et al., 2014). 
As the osteoclast prepares to resorb bone, it attaches to the bone matrix through the sealing 
zone and forms another specific membrane domain, the ruffled border (Väänänen, Zhao, Mulari, 
& Halleen, 2000). The ruffled border is a highly convoluted membrane domain formed by the 
fusion of targeted transport vesicles with the apical membrane (Bellido et al., 2014). This 
membrane, together with its underlying resorption lacuna create the bone-resorbing organelle 
in osteoclasts (Zhao & Väänänen, 2006). 
As mentioned, the main physiological function of osteoclasts is to degrade mineralized bone 
matrix. This involves dissolution of crystalline HAp and proteolytic cleavage of the organic ma-
trix, which is rich in collagen. Before proteolytic enzymes can reach and degrade collagenous 
bone matrix, tightly packed HAp crystals must be dissolved (Väänänen et al., 2000). Osteoclasts 
resorb bone in resorption lacunae by generating a pH gradient between the cell and bone sur-
face (Hienz, Paliwal, & Ivanovski, 2014). The low pH in the resorption lacuna is achieved by the 
action of ATP-consuming vacuolar proton pumps both at the ruffled border membrane and in 
intracellular vacuoles (Sagalovsky, 2013). Protons are provided to the proton pumps by carbonic 
anhydrase II, which is highly expressed in osteoclast cytosol (Baron & Horne, 2005). Carbonic 
anhydrase II converts CO2 and H2O into H
+ and HCO3
- (Nakamura, 2007). The HCO3
- ions are 
exchanged for Cl- through an anion exchanger located in the basolateral membrane, leading to 
continued availability of Cl- for acidification of the resorption lacuna (Sagalovsky, 2013).  The 
hydrochloric acid formed in the resorption lacuna dissolves the HAp component of bone matrix 
and exposes the organic matrix to the enzymatic attack of cysteine proteases and metallopro-
teinases (Bellido et al., 2014; Hienz et al., 2014). The degradation of the demineralized organic 
component of the bone matrix is primarily due to the action of cathepsin K, a member of the 
papain family of cysteine proteases that is highly (although not exclusively) expressed by acti-
vated osteoblasts. Cathepsin readily degrades type I collagen, with an optimal activity at ap-
proximately pH 6.0 (Arnett, 2013). Thereafter, matrix metalloproteinases (MMPs), such as 
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gelatinase A (MMP-2), stromelysin (MMP-3), and collagenase (MMP-1), continue with the matrix 
degradation process (Hienz et al., 2014). 
After matrix degradation, the degradation products are removed from the resorption lacuna 
via a transcytotic vesicle transport process oriented towards the centrally located functional 
secretory domain of the basolateral membrane (Mulari, Zhao, Lakkakorpi, & Väänänen, 
2003).The specific enzyme tartrate-resistant acid phosphatase (TRAP) is located in cytoplasmic 
vesicles, which fuse to the transcytotic vesicles to destroy the endocytosed material. When the 
osteoclast moves away from the resorption lacuna, phagocytes clean up the debris, and osteo-
blasts move in to begin bone formation (Hienz et al., 2014). Additionally, osteoclasts possess 
some mechanisms to guarantee the maintenance of cytoplasmic pH homeostasis, since the ex-
trusion of large amounts of acid would eventually cause the rise of osteoclast intracellular pH 
that would lead to detrimental effects on many cellular processes. Hence, osteoclast intracel-
lular alkalinisation is compensated by the action of the HCO3
−/Cl− exchanger in the basolateral 
membrane (Bellido et al., 2014).  
 
1.5.2.2 Osteoclastogenesis 
The first step in osteoclastogenesis is the commitment of the hematopoietic stem cell to 
the myeloid lineage. The transcription factor PU.1 plays a central role in this step. Its absence 
in vivo results in general myeloid lineage deficiencies (Biosse-Duplan, Horne, & Baron, 2012). 
Another transcription factor that is crucial to early stage of osteoclast development is microph-
thalmia-associated transcription factor (MITF). MITF-deficient mice display a suitable macro-
phage differentiation, but an impaired osteoclast differentiation, which might indicate that 
this transcription factor functions downstream of PU.1 in osteoclast differentiation, and regu-
lates the balance between macrophage and osteoclast fate  (Wei & Wan, 2013). 
Two cytokines are essential and sufficient for osteoclastogenesis, specifically, receptor ac-
tivator of nuclear factor-kappa B (NF-κB) ligand (RANKL) and macrophage colony-stimulating 
factor (M-CSF). M-CSF contributes to proliferation, survival, and differentiation of early osteo-
clasts precursors (Ross, 2006). In turn, RANKL activates downstream signalling pathways that 
control osteoclast differentiation and bone resorption (Gupta et al., 2010) 
M-CSF is a homodimeric glycoprotein produced by several cell types, such as granulocytes, 
endothelial cells, fibroblasts, osteoblasts and lymphocytes (Costa-Rodrigues, Teixeira, Sampaio, 
& Fernandes, 2010). Loss of function mutation in the M-CSF gene originates an osteopetrotic 
phenotype due to the lack of osteoclasts (Provot, Schipani, Wu, & Kronenberg, 2008). The tran-
scription factor PU.1, mentioned earlier, promotes the expression of the M-CSF receptor, c-
Fms, and prepares the cell to respond to M-CSF (Morgan et al., 2010). 
M-CSF binding to c-Fms, a member of the receptor tyrosine kinase family, results in its 
dimerization and auto-phosphorylation. Phosphorylated c-Fms activates ERK via growth factor 
receptor bound protein 2 (Grb-2) son of sevenless (Sos) complex (Grb2/Sos) and protein kinase 
B (Akt) via phosphoinositide 3-kinase (PI3K) (Kikuta & Ishii, 2013). PI3K/Akt signalling pathway 
has been shown to be involved in osteoclasts survival and differentiation (Moon et al., 2012). 
Akt activity was demonstrated to be necessary and in some cases sufficient to promote cell 
survival. Akt target the apoptotic machinery by phosphorylating downstream molecules like 
Bcl-2-associated death promoter (BAD), caspase-9, glycogen-synthase kinase and forkhead fam-
ily members (Glantschnig, Fisher, Wesolowski, Rodan, & Reszka, 2003). The mechanism by 
which Akt regulates the differentiation of osteoclasts was associated to the ability of Akt to 
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regulate nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) signalling cascade, a master 
regulator of RANKL-induced osteoclast differentiation (Moon et al., 2012). The ERK pathway 
has also insightful effects on apoptosis regulation through the post-translational phosphoryla-
tion of apoptotic regulatory molecules such as Bim, myeloid cell leukemia 1 (Mcl-1), and B-cell 
lymphoma 2 (Bcl-2) (Longo et al., 2008) 
Most importantly, M-CSF induces receptor activator of NF-κB (RANK) expression in osteo‐
clast precursor cells, promoting an efficient response to the RANKL-RANK signalling pathways 
(Morgan et al., 2010). 
RANKL is a type II homotrimeric protein of the TNF superfamily. It is expressed at highest 
levels in bone and bone marrow, but is also found in lymphoid tissues (Provot et al., 2008). 
RANKL expression is strongly stimulated by 1,25(OH)2 vitamin D3, prostaglandin (PG) E2, inter-
leukin-1 alpha (IL-1α), and TNF-α (Chambers, 2000). RANKL is a critical cytokine for the final 
stages of osteoblast differentiation, accordingly, the genetic deletion of RANKL leads to an 
osteopetrotic phenotype characterized by a complete absence of osteoclasts (Morgan et al., 
2010; Weitzmann, 2013). RANKL initiates a cascade of events that leads to the activation of a 
nuclear genetic program orchestrated by the transcription factors NF‐kB, c‐Fos/activator pro-
tein 1 (AP‐1) and NFATc1 (Indo et al., 2013). 
The sole receptor for RANKL, found on osteoclast progenitors and their precursors, is RANK 
(Provot et al., 2008). Binding of RANKL to RANK initiates a sequence of signal transduction that 
lead to the differentiation of the early osteoclast precursor into a preosteoclasts. Preosteo-
clasts ultimately fuse with each other into mature multinucleated bone resorbing osteoclasts 
recognized by the expression of key osteoclast markers including TRAP, calcitonin receptors, 
cathepsin K, pp60c-src, MMP9, and the alpha V beta 3 integrin chains (Weitzmann, 2013).  
The soluble receptor, osteoprotegerin (OPG), a member of the tumor necrosis factor recep-
tor (TNFR) superfamily, was shown to act as a decoy receptor, preventing association of RANKL 
with RANK receptor. Knock-out and transgenic overexpression studies in mice demonstrated 
that the deletion of the OPG gene leads to severe bone erosions. OPG–RANKL complex counter-
balances the effect of the RANK–RANKL complex in order to regulate bone resorption and den-
sity (Boyle et al., 2003). 
RANKL activates RANK receptor through the interaction with an adaptor molecule TNF re-
ceptor-associated factor (TRAF). To date, six TRAF proteins have been identified but only TRAF6 
seems to have a critical role in osteoclastogenesis (Yavropoulou & Yovos, 2008). The binding of 
TRAF6 to RANK induces TRAF6 trimerization and leads to the activation of NF-κB and MAPKs 
(Takayanagi, 2008).  
In human, the NF-κB transcription factor family is composed of five members, named p50, 
p52, RelA, c-Rel and RelB. Among NF-κB members, p50 and 52 are crucial for osteoclastogenesis, 
since, animals lacking both the p50 and p52 members develop severe osteopetrosis (Roodman, 
1999). In resting cells, NF-κB are kept silent in the cytosol through their binding to members of 
the inhibitory κB (IκB) family (Remouchamps & Dejardin, 2015). NF-κB activation involves the 
degradation of IκB and the release of NF-kB dimers, which translocate into the nucleus and 
bind to specific DNA sequences triggering the transcription of specific genes (Yavropoulou & 
Yovos, 2008). 
The transcription factor c-Fos, a component of AP-1, is essential for osteoclast differentia-
tion (Matsuo & Ray, 2004). Hence, c-Fos-deficient mice exhibit severe osteopetrosis as a result 
of a complete block of osteoclasts differentiation (Faccio, Choi, Teitelbaum, & Takayanagi, 
2011). On the other hand, the role of the Jun family proteins of AP-1 has been shown to be 
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redundant. Mice lacking Jun proteins are embryonically lethal, yet, although deficiencies in 
JunB or c-Jun lead to a significant decrease in osteoclast formation, the blockage of osteoclas-
togenesis doesn’t occur, suggesting that Jun members can substitute each other (Faccio et al., 
2011).  
RANKL-induced activation of NF-κB and c-Fos has been shown to be essential for the induc-
tion of NFATc1 (Choi et al., 2013). The role of NFATc1 in osteoclastogenesis was proposed after 
in vitro observations that NFATc1-deficient embryonic stem cells fail to differentiate into os-
teoclasts, and that ectopic expression of NFATc1 in the absence of RANKL promotes bone mar-
row-derived precursor cell differentiation in osteoclasts (Takayanagi, 2008). 
The majority of MAPKs are activated downstream of RANK and can relay RANK stimulation 
to the cellular response (Wada, Nakashima, Hiroshi, & Penninger, 2006). MAPKs (particularly 
JNK) were shown to be involved in the activation of AP-1 components and therefore perform a 
role in osteoclastogenesis, however the molecular mechanisms involved are not clear to date  
(Faccio et al., 2011; Wada et al., 2006). Hotokezaka and his co-workers used p38-MAPKs and 
ERKs specific inhibitors to study the involvement of MAPKs in osteoclastogenesis. The authors 
suggested that osteoclastogenesis is regulated under a balance between ERK and p38 pathways 
and that the ERK pathway negatively regulates osteoclastogenesis while the p38 pathway does 
so positively (Hotokezaka et al., 2002).  
 
 
1.6 Bone Modelling and Remodelling 
 
The coordinated actions of osteoblasts, osteocytes and osteoclasts occur within two biolog-
ical contexts, namely, bone modelling and remodelling (Baron & Horne, 2005). 
Bone modelling is defined as either the formation of bone by osteoblasts or resorption of 
bone by osteoclasts on a given surface (Allen & Burr, 2014). Thus, this process is responsible 
for the gain in skeletal mass and the changes in skeletal size and shape taking place during the 
growth period (Delgado-Calle, Garmilla, & Riancho, 2012). Although the processes of formation 
and resorption during bone modelling are locally independent, they are not globally independ-
ent since both processes occur simultaneously and must be coordinated to shape bone (Allen & 
Burr, 2014). 
The coupling of osteoclast and osteoblast activities at one specific bone area is known as 
bone remodelling (Sims & Martin, 2014). Bone remodelling replaces old bone by new bone tissue, 
throughout life, and specifically in the adult skeleton, to maintain bone mass, repair bone 
microfractures, sustain mineral homeostasis, and ensure mechanical competence by modifying 
the microarchitecture (Delgado-Calle et al., 2012) 
Bone remodelling can be classified as targeted or stochastic. Targeted remodelling is char-
acterized by a local signalling event that directs osteoclasts to a specific location to begin 
remodelling. The most accepted signalling events are bone microdamage and osteocyte apop-
tosis, which have been demonstrated to be connected (Allen & Burr, 2014). In fact, it has been 
proposed that osteocytes are able to sense bone deformation and to detect microdamage in 
old bone, and transmit signals of an unknown nature to recruit osteoclast precursors to a spe-
cific bone site and trigger the remodelling process (Feng & McDonald, 2011). In contrast, sto-
chastic remodelling is not site-dependent, although probably is not also a completely random 
process (Burr, 2002). This process occurs in response to systemic hormones, like PTH, thyroxine, 
growth hormone and estrogen (Eriksen, 2010). While, targeted remodelling plays an important 
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role in the maintenance of skeletal integrity, stochastic remodelling enables bone to fulfil its 
metabolic requirements (Fuchs, Warden, & Turner, 2009). 
Remodelling takes place within temporary anatomical structures, known as bone multicel-
lular units (BMUs), which consist of clusters of bone-resorbing osteoclasts and bone-forming 
osteoblasts (Raggatt & Partridge, 2010). The remodelling cycle encompasses four sequential 
phases, respectively, activation, resorption, reversal, and formation.  
The activation phase is characterized by the recruitment of osteoclast precursors from 
blood circulation to the bone surface. This phase involves the interaction of osteoclast and 
osteoblast precursor cells, which leads to the differentiation, migration, and fusion of the large 
multinucleated osteoclasts (Kini & Nandeesh, 2012; Raisz, 1999).  
Once mature osteoclasts are present, bone lining cells retract from the bone surface ex-
posing the mineralized matrix to bone-resorbing cells (Bellido et al., 2014; Raisz, 1999). This 
process appears to be stimulated either by the osteoclasts as they approach to the surface or 
by the same signals that initiate the remodelling process (Bellido et al., 2014).  Subsequently, 
osteoclasts adhere to bone and resorb this tissue by means of acidification and proteolytic 
digestion (Manolagas, 2000; Raisz, 1999). The regulatory mechanisms that arrest osteoclastic 
activity are poorly understood. It was suggested that since osteoclasts have a limited lifespan, 
they eventually undergo apoptosis after an extensive resorptive activity. Additionally, it was 
also considered that TGF-β or related peptides released from the matrix during the resorption 
phase could inactivate osteoclasts (Hill, 1998). 
When resorption has been completed, the reversal phase begins. In this phase, mononuclear 
cells of an undetermined lineage remove the undigested demineralized collagen matrix from 
the resorption lacunae and prepare bone surface for subsequent osteoblast-mediated bone for-
mation (Raggatt & Partridge, 2010). The reversal phase couples bone resorption to bone for-
mation (Delaisse, 2014). Bone matrix-derived factors released during bone resorption, such as, 
TGF-β, IGF-1, IGF-2, BMPs, platelet-derived growth factor (PDGF), and fibroblast growth factors 
(FGF) were suggested to link these two phases, namely by recruiting osteoblasts into the reab-
sorbed area (Kini & Nandeesh, 2012; Raggatt & Partridge, 2010). 
During formation phase of the remodelling cycle, the cavity created by resorption can be 
completely filled in by successive layers of osteoblasts, which differentiate from their mesen-
chymal precursors and deposit a mineralizable matrix (Raisz, 1999). 
Imbalances in bone remodeling can result in severe perturbations in skeletal structure and 
function, leading to conditions such as osteoporosis, osteosclerosis, and osteopetrosis (Boyle et 
al., 2003). 
 
 
1.7 Bone and Calcium Homeostasis 
 
The total amount of calcium in the human body ranges from 1000 to 1200 g (Blaine, 
Chonchol, & Levi, 2014). Calcium accretion begins throughout the third trimester of fetal life 
and increases during childhood, adolescence, and adulthood before peaking in early adulthood 
and declining thereafter (about 1 to 2% per year) (Unnanuntana, Gladnick, McArtur, McCarthy, 
& Lane, 2010). 
Over 99% of total body calcium is found as HAp crystals in bone. Bone calcium contributes 
to the mechanical weight-bearing properties of the skeleton and, provides a dynamic store to 
maintain the intra- and extracellular calcium pools (Peacock, 2010; Review, 2011). Non-bone 
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calcium, which accounts for less than 1% of total body calcium is found in the intracellular and 
extracellular fluid compartments, including blood (Favus, Bushinsky, & Lemann, 2006). 
Approximately 0.9% of total body calcium content is intracellular (Shahay, 2013). Intracel-
lular calcium is a crucial regulator of numerous cellular events, including muscle contraction, 
hormone secretion, glycogen metabolism, and cell division (E.M. Brown, 1991). The intracellu-
lar concentration of calcium is approximately 0.15 µM (Hruska, Levi, & Slatopolsky, 2007). At 
the intracellular level, calcium homeostasis is maintained through the influx of extracellular 
calcium or from release of intracellular calcium stores (Comission, 2003). 
Extracellular calcium accounts for roughly 0.1% of the total body calcium content (Calvi & 
Bushinsky, 2008; Shahay, 2013). Extracellular calcium not only provides a steady supply of cal-
cium for intracellular use but also plays an important role in clotting and membrane integrity 
(E.M. Brown, 1991). Serum calcium concentration is held in a very narrow range, usually from 
2.2 to 2.6 mM (or 8.8 to 10.4 mg/dl) (Peacock, 2010). Extracellular calcium exists in three 
forms, protein-bound, complexed, and ionized. Approximately 40% of serum calcium is bound 
to proteins, namely albumin. Another 10% is complexed with various chelators, such as citrate, 
phosphorus and sulfate. The remaining 50% of serum is found in the ionized form (Calvi & 
Bushinsky, 2008; Favus et al., 2006). 
The biological activity of calcium is attributed to the ionized fraction, which is readily ex-
changeable with pools of calcium in bone, blood, and intracellular sites (Favus et al., 2006). 
To avoid calcium toxicity, the concentration of serum ionized calcium is tightly maintained 
within a physiologic range of 1.10 to 1.35 mM (4.4 to 5.4 mg/dl) (Peacock, 2010).  
The extracellular ionized calcium concentration is tightly controlled by the concerted ac-
tion of calcium absorption in the intestine, reabsorption in the kidney, and exchange from bone, 
which are all under the control of the calciotropic hormones, such as PTH, 1,25-dihydroxyvita-
min D (1,25(OH)2D; calcitriol) and calcitonin (Blaine et al., 2014; Flynn, 2003; Mundy & Guise, 
1999).  
During bone remodeling, osteoclasts and osteoblasts function in local environments charac-
terized by dramatic fluctuations in extracellular calcium concentrations (Silver, Munflls, & 
Etherington, 1988). Elevation of extracellular calcium has been shown to inhibit osteoclastic 
bone resorption and to stimulate proliferation and chemotaxis of osteoblasts. Therefore, cal-
cium released by bone resorption may perform an important role in the coupling of bone re-
sorption and bone formation (Sugimoto et al., 1993). 
 
1.7.1 Parathyroid Hormone, Calcitriol and Calcitonin 
Parathyroid hormone (PTH) is secreted by the parathyroid glands as a polypeptide (Juppner, 
Gadella, Brown, Kronenberg, & Potts, 2010). Secretion of PTH is highly dependent on the ion-
ized calcium concentration and represents a simple negative feedback loop. Calcium level is 
sensed by the calcium-sensing receptor (CASR) in the parathyroid chief cells. Hence, low cal-
cium levels stimulate PTH secretion, whereas, high calcium levels supress, although not entirely, 
PTH secretion (V. David & Quarles, 2011; Mundy & Guise, 1999).  
Elevated levels of PTH target the PTH receptor on kidney to increase renal reabsorption of 
calcium and to promote the conversion of 25(OH)D into the active state of 1,25(OH)2D, by 
increasing the activity of the renal 1-α-hydroxylase (Blaine et al., 2014; V. David & Quarles, 
2011; Moe, 2008). An elevated level of 1,25(OH)2D increases intestinal absorption of calcium 
and phosphate (V. David & Quarles, 2011).  In bone, both PTH and 1,25(OH)2D promote bone 
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resorption and a calcium and phosphate efflux by increasing the number of osteoclasts, indi-
rectly by binding initially to osteoblasts and stimulate RANKL expression on their membrane 
(Lieben & Carmeliet, 2013; Takahashi, Udagawa, & Suda, 2014). Finally, the increased serum 
calcium acts on CASR to reduce PTH secretion at the level of the parathyroid glands, thus 
completing the endocrine feedback loop (V. David & Quarles, 2011; Moe, 2008).  
Calcitonin is a 32-amino acid peptide that is synthesized and secreted by the parafollicular 
cells of the thyroid gland. Increases in ionized calcium produce an increase in calcitonin secre-
tion, and conversely, a fall in the ambient calcium concentration inhibits calcitonin secretion 
(Mundy & Guise, 1999). The principal target organ for calcitonin is bone, however renal excre-
tion of calcium and phosphate are also affected. Calcitonin reduces blood calcium by supressing 
bone resorption and increasing osteoid mineralization. This peptide hormone binds to its re-
ceptor on the surface of osteoclasts and inhibits osteoclastic resorption by affecting their actin 
cytoskeleton (Chiappelli, 2011).  
 
 
1.8 Lanthanides 
 
The lanthanides (Ln) are an exceptional group of fourteen elements, with unique and dis-
tinctive physicochemical and magnetic characteristics, ranging from Cerium (Ce58) to Lutetium 
(Lu71) (Madan & Prakash, 2001; Raj, 2008).  
These elements were originally called rare earths due to their natural occurrence as metal 
oxides, which in some ways resemble calcium, magnesium an aluminium oxides known as com-
mon earths. The name rare earths is a misnomer since these elements are neither rare or earths 
(Sastri, Perumareddi, Rao, Rayudu, & Bünzli, 2003). In fact, lanthanides are more common than 
gold, silver and platinum (Leonard, Nolan, Stomeo, & Gunnlaugsson, 2007).  
The elements of this series are called lanthanides since they follow lanthanum (La57) in the 
periodic table. Although lanthanides are confined to the fourteen elements following La in the 
periodic table this element is generally included in this group since it presents the main features 
of the other elements of the series (Madan & Prakash, 2001; Raj, 2008).  
Lanthanides are elements in which the f orbitals are partly or completely filled, while the 
outermost p and d orbitals are empty. Since the f orbitals do not have as much effect on the 
chemical properties as the p, and d, they are chemically very similar (Abdelrahman, 2011). 
Lanthanides generally favour tripositive oxidation state (Ln3+). Hence, they are highly elec-
tropositive and predominantly ionic in nature. Even thought, tetravalent and divalent forms 
exist as well, only cerium (Ce4+) and europium (Eu2+) are stable enough to persist in aqueous 
solutions (C.H.  Evans, 1990). 
A particular feature of these elements consists on the decrease in the atomic size and radius 
along with the increase in the atomic number (La 1.06 Å and Lu 0.85 Å) (Fricker, 2006). 
This phenomenon, called lanthanide contraction, is attributed to the shielded 4f-orbital, 
which cannot compensate the effect of increased nuclear charge. Thus enhanced nuclear at-
traction is exerted upon the whole electron cloud which finally shrinks and leads to the con-
traction of the entire ionic structure (Madan & Prakash, 2001).  
The preferred coordination number of all lanthanides is 8–9, but complexes of 6–12 coordi-
nation are quite stable. In aqueous solution, the hydration shell of lanthanides is between 9–12 
water molecules, but this number has not been unequivocally determined. The ionic character 
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of complexes of trivalent lanthanide ions is very high, with a typical order in strength of bonding 
of O > N > S (Jakupec, Unfried, & Keppler, 2005). 
 
1.8.1 Biochemistry of Lanthanides 
The research on the biochemical aspects of lanthanides began when the ability of these 
elements to substitute for a large number of metallic ions, such as calcium (Ca2+), magnesium 
(Mg2+), iron (Fe2+), and manganese (Mn2+) was first stated. Among these metallic ions, calcium 
(Ca2+) is of particular interest due to its importance in cellular metabolism (C.H. Evans, 1983).  
Lanthanides ions (Ln3+), as shown in Table 1.1, have similar ionic radii to calcium, but by 
virtue of possessing a higher charge-to-volume-ratio, they have a stronger binding to water 
molecules, an increased stability of analogous complexes, and a preference for higher coordi-
nation numbers (Fricker, 2006; Jakupec et al., 2005). Even though, lanthanide ions are able to 
replace calcium in many biomolecules they not necessarily substitute its functionality. For ex-
ample, the substitution of lanthanide ions for calcium ions in enzymes generally results in an 
inhibition of the enzyme process (Jakupec et al., 2005). In addition, there are also some cal-
cium binding sites that totally refuse lanthanide ions binding, for instance, lanthanide ions 
cannot replace calcium  in scallop myosin or concanavalin A (Madan & Prakash, 2001). 
Since larger lanthanide ions are generally closer in ionic radius to calcium ions, a relation-
ship between ionic radius and activity has been described. Yet, in some cases these relationship 
is not observed. For instance, the inhibition of Ca2+/Mg2+-ATPase of skeletal muscle sarcoplas-
mic reticulum decreases from La3+ to Lu3+, while the activation of α-amylase tends to increase 
from La3+ to Lu3+. These behaviours are thought to occur due to the decrease of free energy 
upon binding interaction (Sastri et al., 2003).  
Lanthanide ions are generally unable to penetrate cellular membranes of healthy cells, 
however they can still exert influence on transmembrane processes (Korenevskii, Sorokon, & 
Karavaiko, 1997). Binding of lanthanides to membrane proteins stabilizes the phospholipid 
membranes, increases their rigidity and alters their surface charge towards higher electroposi-
tivity. This effect further leads to increasing membrane potential and resistance and conse-
quently to a dysfunction of the voltage-dependent calcium channels. Calcium entrance may 
also occur by receptor operated calcium channels (C.H.  Evans, 1990).  
Accordingly, lanthanide ions were used in several studies to explore the mechanism of cal-
cium influx and calcium-related downstream events. Although the reported results are discrep-
ant, depending on the experimental conditions, overall it was observed that lanthanide ions 
suppress several agonist-induced calcium influxes by blocking the calcium channels (K. Wang, 
Cheng, Yang, & R., 2003). Mlinar and Enyeart showed that lanthanide ions block the T-type 
calcium channels by pore occlusion with a potency that varies inversely with ionic radius (Mlinar 
& Enyeart, 1993). In contrast, lanthanide  ions inhibit L-type calcium channels with a potency 
that varies directly with ionic radius (Lansman, 1990).  
Moreover, lanthanide ions were also shown to be able to induce the increase of calcium 
concentration in a variety of cells, such as, hepatocytes (by La3+) and osteoblasts (by Gd3+), by 
activating a membrane-bound CaSR which responds to extracellular calcium and releases cal-
cium from the intracellular pool (K. Wang et al., 2003). 
However, lanthanides can also exert their influence on cellular functions by other means 
than inhibiting calcium fluxes.  Lanthanide ions have been shown to coordinate with further 
membrane structures, such as receptors for acetylcholine and Na+/K+-ATPase (P. David & Karlish, 
36 
 
1991; Rübsamen, Hess, Eldefrawi, & Eldefrawi, 1976). Moreover, the cyclic adenosine mono-
phosphate (cAMP) content of hepatocytes was increased upon incubation with Ce3+ in a concen-
tration-dependent manner, wich suggested that lanthanide ions can also trigger cAMP signaling 
system (K. Wang et al., 2003).  
The duality and diversity are common features in the biological effects of lanthanides. In 
many cases, they affect a biological event from opposite sides (K. Wang et al., 2003). This dual 
behaviour points toward the use of the positive effects indorsed by lanthanides in the interven-
tion of pathologic events. However, the clinical success of these approaches will depend on the 
ability to modulate the opposing effects (K. Wang et al., 2003). 
 
Table 1.1 — Properties of calcium and lanthanides ions (Sastri et al., 2003). 
Property Ca2+ Ln3+ 
Coordination number 
6-12 reported 
6 or 7 favored 
6-12 reported 
8 or 9 favored 
Coordination geometry Highly flexible Highly flexible 
Donor atom preference O >> N >> S O >> N >> S 
Ionic radius (Å) 1.00 – 1.18 (CN 6-9) 0.86 – 1.22 (CN 6-9) 
Type of bonding Ionic Ionic 
Hydration number 6 8 or 9 
Water exchange constants (s-1) ≈ 5 x 108 ≈ 5 x 107 
Diffusion coefficient (cm2/s x 105)  1.34 La3+, 1.3 
Crystal-field stabilization None Negligible 
 
1.8.2 Lanthanide Induced-Proliferation, Apoptosis and Differentiation 
Likewise other hormetic agents, cell proliferation is promoted by lanthanide ions only in a 
narrow range of low concentration. Beyond an upper limit the effect becomes inhibitory. This 
concentration dependency has been reported in different cell types, such as, fibroblasts, and 
hepatocytes (Preeta & Nair, 1999; Rai et al., 1997).  
Cell proliferation promoted by lanthanide ions is associated with enhanced DNA, RNA and 
protein synthesis (K. Wang et al., 2003). Furthermore, Sarkander and Brade highlighted that 
different effects of lanthanides on RNA synthesis are due to variations in their ionic radius and 
that those effects depend on species, cells and conditions examined (Sarkander & Brade, 1976). 
Since intracellular calcium act as mediator of cell proliferation, lanthanides may exert their 
influence on cell proliferation by increasing intracellular calcium concentrations. Gadolinium, 
a stretch-activated channel blocker, inhibited strain-induced 45Ca2+ influx and suppressed 
strain-enhanced DNA synthesis in rat fibroblasts (M. Liu, Xu, Tanswell, & Post, 2005). Moreover, 
some studies indicated that lanthanide ions, as agonists of CaR, are able to induce cell prolif-
eration through the inositol trisphosphate (IP3) signalling pathway (E. M. Brown, Fuleihan, Chen, 
& Kifor, 1990). 
Aside from promoting cell proliferation, lanthanides were also documented to have the 
ability to inhibit cell proliferation. Weiss et al. demonstrated the ability of lanthanides to block 
store-operated calcium entry and inhibit human colon carcinoma cells proliferation (Weiss, 
Amberger, Widschwendter, Ofner, & Dietl, 2001). The effect of lanthanides on cell proliferation 
had been previously demonstrated by Sato and its co-workers. In this work, the growth rates of 
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melanoma cells in the presence of 1 mM of metal ions (La3+, Ce3+, Nd3+, Sm3+, Gd3+, Yb3+, Al3+) 
were significantly lower than that of control cells. Measurements of cell cycle indicated that 
the metal ions arrested the transitions from G0/G1 to S state (Sato, Hashizume, Hotta, & 
Okahata, 1998).  
Effects of lanthanides on cell apoptosis was described in several cell types, such as rat skin 
fibroblasts, HeLa and PC12 cells (K. Wang et al., 2003). Macrophages apoptosis was shown to 
be induced by Gd3+ in a concentration-dependent manner. Higher concentrations of Gd caused 
more rapid and widespread cell death than the lower concentrations (Mizgerd, Molina, Stearns, 
Brain, & Warner, 1996).  
The mechanisms underlying lanthanides induced-apoptosis are not completely stablished, 
but the increase of intracellular calcium concentration is known to play an important role in 
this event, since it activates the endonucleases and protein kinases and mediates DNA cleavage 
and apoptosis-related gene expression, respectively (K. Wang, Li, Cheng, & Zhu, 1999).  
The interactions of lanthanides with mitochondria was also proposed to explain lanthanide 
induced-apoptosis. Incubation of mitochondria isolated or in whole cell with La3+, Gd3+ and Yb3+ 
resulted in mitochondria swelling, increased membrane fluidity, decrease of mitochondrial 
membrane potential and release of cytochrome c, all characteristics of pre-apoptotic events. 
Cellular reactive oxygen species (ROS) level was shown to increase in the presence of La3+, Gd3+ 
and Yb3+, suggesting that perhaps lanthanide-induced apoptosisis is related with ROS induction 
(H. Liu, Yuan, Yang, & Wang, 2003). 
Although poorly documented, influence of lanthanides on cell differentiation is thought to 
result of the interference with calcium-depending processes. La3+ and Gd3+ inhibit electrically 
stimulated differentiation of PC12 cells. The differentiation was explicated with electrically 
induced calcium influx (Kimura, Yanagida, Haruyama, Kobatake, & Aizawa, 1998). Another 
study suggested that La3+ inhibit calcium mediated keratinocyte differentiation. According to 
the authors, La3+ enters cells and inhibits calcium mediated keratinocyte differentiation both 
by blocking calcium influx and by blocking calcium regulated intracellular processes, such as 
transglutaminase directed cornified envelope formation (Pillai & Bikle, 1992). 
 
1.8.3 Lanthanides Distribution in the Skeleton 
The distribution of lanthanides in bone was studied by Durbin in 1962, using rat models. 
Although this work has already been developed a few decades ago, it still epitomizes the utmost 
complete systematic comparative study of lanthanides in the same animal strain, under the 
same conditions. The results obtained point out to an increased bone accumulation by dint of 
a decrease of the ionic radius (Durbin, 1962). 
The development of biokinetic models based on this work, and on later works, made possi-
ble the realization of studies to predict the behaviour of the lanthanides in the human body. 
Using this models it was observed that both the initial deposition pattern and the further re-
distribution of the metals within the skeleton depends on the metal charge. In addition, it was 
noticed that lanthanides show no initial diffuse distribution into the bone volume (as with other 
metals, such as, uranium or neptunium), in contrast they tend to be more concentrated on 
resorbing and resting bone surfaces, such as, Haversian canals, endosteum, and periosteum. 
This work showed also an equal initial distribution of lanthanides in the trabecular and the 
cortical surfaces (Taylor & Leggett, 2003). 
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Lanthanides show a prolonged skeletal retention, with a biological half-life of almost two 
decades. Throughout bone turnover process, lanthanides are removed from bone and are laid 
down on new bone surfaces which supports their homogeneous distribution within the bone 
volume and, accordingly, within the skeleton. Since this process occurs gradually, only a small 
proportion of the element is released into the circulation and eliminated from the body (Vidaud, 
Bourgeois, & Meyer, 2012) 
Lanthanum carbonate was strongly studied because it presents phosphate-binding proper-
ties, being used for the treatment of hyperphosphatemia. Hence, lanthanum distribution in 
bone was mapped, using scanning X-ray microfluorescence, in rats treated with high doses 
(>1000 mg/kg/day) of lanthanum carbonate. Lanthanum was found at the edge of mineralized 
bone, on both actively mineralizing and quiescent sites of bone turnover, and also deep inside 
the trabecular bone and in cells in close proximity to the resorption lacunae (Behets et al., 
2005). 
 
1.8.4 Lanthanides Interaction with Bone Matrix 
The outstanding affinity of lanthanides for bone results from the ability that both the min-
eral and the organic components of the bone matrix have to intervene in the binding of multi-
valent cations to bone. Indeed, in vitro studies have shown that the collagen and the glycopro-
teins present in the bone matrix are very efficient binders for lanthanides (Vidaud et al., 2012). 
Nouisiainen et al. investigated calcium, magnesium and lanthanum binding to bovine bone OC. 
The results indicated that lanthanum ion bound to OC (although in a lesser extensive manner 
than either calcium or magnesium) and did not induce the protein dimerization (Nousiainen et 
al., 2002). 
Both natural and synthetic HAp present the ability to undergo cationic and anionic substi-
tution (Cawthray, Creagh, Haynes, & Orvig, 2015). Accordingly, lanthanides are able to replace 
calcium ion sites within HAp, without altering the hexagonal apatite structure, due to their 
similarity to calcium (Vidaud et al., 2012). 
A systematic study of the isomorphous substitution of lanthanides in synthetic HAp showed 
that the maximum incorporation of lanthanides decreases along the element series, contradict-
ing the deposition of these elements in the skeleton (which increases along the series) 
(Ardanova et al., 2010). Furthermore, in vivo studies on rats with lanthanum carbonate demon-
strated that lanthanum replaces no more than 1 out of 2000 calcium atoms within the HAp 
lattice (Behets et al., 2005). Thus, although lanthanides are able to simply replace calcium ions 
in the apatite crystal, the mechanism of their incorporation in bones is apparently more com-
plex (Vidaud et al., 2012).  
 
1.8.5 Lanthanides Interaction with Bone Cells 
Due to the affinity of lanthanides for bone, the biological activity of these elements has 
been investigated in order to understand their ability to modulate bone tissue metabolism and 
the bone regeneration process (J. Coelho et al., 2012).  
Several experimental in vivo tests were conducted to assess the biological effects of this 
elements. In one of this works, the effects of lanthanum on the femur bone mineral of male 
Wistar rats after oral administration of lanthanum nitrate over a 6-month period was investi-
gated. Lanthanum was found to accumulate in the bone tissue of male Wistar rats. Moreover, 
a decrease in the mineral-to-matrix ratio and an increase in carbonate content was shown by 
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thermogravimetric analysis. Additional methodologies revealed a smaller mean thickness of the 
mineral crystals in the bone of lanthanum nitrate-treated rats. Accordingly to the results ob-
tained, the authors suggested an obstruction of bone maturation prompted by lanthanum (J. 
Huang et al., 2006). 
Behets et al. investigated the effect of lanthanum carbonate on bone histology in rats with 
normal renal function and with chronic renal failure, after oral administration of the compound 
for 12 weeks. The results obtained indicated that the administration of lanthanum carbonate 
did not cause noticeable effect on bone in rats with normal renal function, which contradicts 
the results mentioned above. Nevertheless, at higher doses this compound was shown to cause 
an impairment of bone mineralization in rats with chronic renal failure (Behets et al., 2004). 
Due to the conflicting results obtained in the in vivo studies, the effect of these elements 
on bone cells in vitro started to be also addressed by several authors. One of the most studied 
lanthanides is lanthanum, which due to its pronounced similarity to calcium, has been recog-
nized as a “bone-seeking element” (X. Wang, Yuan, Huang, Zhang, & Wang, 2008). 
Liu et al. studied the effect of lanthanum on osteoblastic differentiation of primary rat 
MSCs. Lanthanum inhibited the osteoblastic differentiation in the early and middle stages of 
culture, as demonstrated by the decrease in the ALP activity and OC expression. Furthermore, 
MAPK kinase inhibitor was shown to completely block the inhibitory effect of lanthanum on ALP 
activity of MSCs suggesting that the response induced by lanthanum occurred by a MAPK-kinase 
dependent mechanism (H. Liu, Zhang, Xu, & Wang, 2006). 
The enhancement of osteoblastic differentiation of calvaria-derived rat osteoblasts by lan-
thanum was shown in another report by Wang et al. The authors observed an increased expres-
sion of osteoblast-specific genes (Cbfa-1, OPN, and BSP) upon lanthanum treatment, yet, no 
changes were observed concerning the expression of type I collagen. Also, they suggested that 
lanthanum effect on osteoblasts was, at least, partially mediated by the enhanced phosphory-
lation of ERK pathway, since the inhibition of this pathway was shown to suppress the effects 
perceived (X. Wang et al., 2008). 
The formation and bone resorbing activity of rabbit osteoclast-like cells was also shown to 
be affected by lanthanum. The promotion or inhibition of osteoclasts formation and activity 
was shown to be dependent on the assayed concentration (J. Zhang , Xu, Wang, & Yu, 2003). 
The biological effects of other lanthanides rather than lanthanum were already studied 
(such as, neodymium, samarium, and gadolinium) and the majority of the literature reports 
corroborate the ability of lanthanides to modulate the behaviour of bone-relevant cellular pop-
ulations (J. Coelho et al., 2012). 
 
1.9 Chapter Insights and Research Objectives 
 
Bone is the dynamic tissue that comprises functionally distinct and unique cell populations 
that support the biochemical, mechanical and structural integrity of the skeleton (Fitzpatrick, 
2004). Bone undergoes continuous remodeling throughout life, an active and dynamic process 
that depends on the balance between bone resorption by osteoclasts and bone deposition by 
osteoblasts (Rucci, 2008). An imbalance in these processes can lead to either an increase or 
decrease in bone mineral density, causing the structural deterioration of bone (Datta et al., 
2008).  
Lanthanides are a group of metal ions with similar properties, which have been recognized 
for their diversity of biological effects and outstanding potential in medical applications (Wang, 
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Li et al. 1999). More recently, these elements have been the focus of several investigations 
related to their potential to modulate bone tissue metabolism and the bone regeneration pro-
cess due to their high affinity for bone and their ability to exchange with calcium in bone and, 
consequently, affect the remodeling cycle, by modulating osteoblast and osteoclast develop-
ment (Pidcock and Moore 2001; Webster, Massa-Schlueter et al. 2004; Barta, Sachs-Barrable et 
al. 2007).  
Although the biological effect of lanthanides has been extensively studied, few reports have 
focused on the effect of these elements on human bone cells. Accordingly, the aim of this study 
was to investigate the cellular and molecular effects of three different lanthanides (cerium, 
lanthanum and praseodymium) at different concentrations (10-7 to 10-3 M) on the proliferation 
and differentiation of human osteoblasts and osteoclast precursor cells. Zinc and magnesium 
were used as reference physiological cations, since their effect on bone cells development is 
already well-stablished. Moreover, it was also assessed the involvement of some signaling path-
ways important for osteoblastogenesis and osteoclastogenesis in cellular responses of bone cells 
cultured in the presence of these elements.  
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Chapter 2 
 
 
Materials and Methods 
 
 
 
2.1 Materials 
 
All cell culture chemicals and supplies were acquired from Merck and Sigma Aldrich (St. 
Louis, MO) unless otherwise noted. All tissue culture flasks and plates were obtained from Corn-
ing (Corning, NY). 
 
 
2.2 Methods 
 
2.2.1 Osteoblastic Cell Cultures 
Osteoblast precursor cells were obtained from femur heads of patients with ages comprised 
between 25 and 45 years old, undergoing orthopaedic surgery procedures, after informed con-
sent, as previously described (Costa-Rodrigues et al., 2010). Briefly, bone was broken in small 
pieces, which were maintained in α-minimal essential medium (α-MEM) containing 10% fetal 
bovine serum, 100 IU/mL penicillin, 2.5 μg/mL streptomycin, 2.5μg/mL amphotericin B and 50 
μg/mL ascorbic acid. At approximately 70-80% confluence, cells were enzymatically detached 
with 0.05% trypsin and 0.5 mM ethylenediamine tetraacetic acid (EDTA). 
Cells, seeded at 2 x 104 cells/cm2, were maintained in α-MEM supplemented with 10% fetal 
bovine serum, 100 IU/mL penicillin, 2.5 μg/mL streptomycin, 2.5 μg/mL amphotericin B, 50 
μg/mL ascorbic acid.  
 
2.2.2 Osteoclastic Cell Cultures 
Blood was collected from healthy donors with ages comprised between 25 and 35 years old, 
after informed consent. Peripheral blood mononuclear cells (PBMCs) were isolated as described 
previously (Costa-Rodrigues, K.A., Teixeira, & Fernandes, 2012). Shortly, blood was diluted 
(2:1) with phosphate-buffered saline (PBS) and applied on top of Ficoll-PaqueTM PREMIUM (GE 
Healthcare Bio-Sciences, Little Chalfont, UK). After centrifugation at 400g for 30 minutes, PBMC 
were collected and washed twice with PBS. On average, for each 100 mL of processed blood 
about 60 x 106 PBMC were obtained. 
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PBMC, seeded at 1.5 x 106 cells/cm2, were maintained in α-MEM supplemented with 30% 
autologous human serum, 100 IU/mL penicillin, 2.5 μg/mL streptomycin, 2.5 μg/mL amphoter‐
icin B, 2 mM L-glutamine.  
 
2.2.3 Exposure to Lanthanides 
Osteoblastic and osteoclastic cell cultures, established as described above, were cultured 
for 24 hours. Following this, the culture medium was removed and replaced with one containing 
the the osteogenic enhancers 10 mM β-glycerophosphate and 10 nM dexamethasone, in the case 
of osteoblastic cultures, or the  osteoclastogenic promoters 25 ng/mL M-CSF (R&D Systems, 
Minneapolis, USA) and 40 ng/mL RANKL (Insight Biotechnology, London, UK), in the case of 
PBMC cultures (M. J. Coelho & Fernandes, 2000; Costa-Rodrigues, Fernandes, & Fernandes, 
2011).  
Moreover, cell cultures were further treated with zinc, magnesium (as reference physiolog-
ical cations) and lanthanides (cerium, lanthanum and praseodymium) at concentrations of 10-7 
M to 10-3 M. The concentration range tested was based on information regarding the literature. 
Cell cultures performed in the absence of zinc, magnesium and lanthanides were used as neg-
ative controls.  
The culture medium was changed once a week, and the cations were renewed at each 
medium change. Cell cultures were incubated at 37ºC in a 5% CO2 humidified atmosphere, for 
21 days. 
 
2.2.4 Osteoblastic and Osteoclastic Cell Response to Lanthanides 
Osteoblast precursor cells cultured in the presence of zinc, magnesium and lanthanides at 
10-7 M to 10-3 M, were analysed at days 14 and 21, for DNA content, apoptosis, ALP activity, 
histochemical staining of ALP and collagen, and F-actin staining. Osteoblast precursor cells 
cultured in the presence of the lowest concentration that caused statistically significant inhi-
bition of ALP-related parameters, were further characterized for the involvement of several 
common osteoblastogenesis-related signalling pathways. 
PBMC cultured in the presence of zinc, magnesium and lanthanides at 10-7 M to 10-3 M, were 
assessed at days 14 and 21, for DNA content, apoptosis, TRAP activity, number of TRAP-positive 
multinucleated cells, and the presence of cells displaying F-actin rings and expressing vitron-
ectin (VNR) and calcitonin receptors (CTR). PBMC cultured in the presence of the lowest con-
centration that caused statistically significant inhibition of TRAP-related parameters, were fur-
ther characterized for the involvement of several common osteoclastogenesis-related signalling 
pathways. 
 
2.2.4.1 DNA content 
DNA quantification was performed using PicoGreen® dsDNA kit (Molecular Probes, Eugene, 
USA), according to the manufacturer’s instructions. Briefly, PBMC and osteoblast precursor cell 
cultures, at days 14 and 21, were washed twice with PBS and solubilized with 0.1% (V/V) Triton 
X-100 for 15 minutes. PicoGreen® dye was diluted by making a 1:200 dilution of the concen-
trated dye solution in 1xTE (10 mM Tris-HCl, 1 mM EDTA, pH 7.5). Posteriorly, diluted 
PicoGreen® was added to each sample in a black 96-well plate and incubated for 2 minutes at 
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room temperature, protected from the light. Fluorescence was measured at 485/520 nm (ex-
citation/emission) in an ELISA plate reader (Synergy HT; Biotek). The results of DNA content 
were express in fgDNA. 
 
2.2.4.2 Apoptosis 
Apoptosis quantification was performed using EnzCheck® Caspase-3 Assay Kit #2 (Molecular 
Probes, Eugene, USA), according to the manufacturer’s instructions. Briefly, osteoblast precur-
sor cell and PBMC cultures, at days 14 and 21, were washed twice with PBS and solubilized with 
0.1% (V/V) Triton X-100 for 15 minutes. 2x Reaction Buffer was prepared with 5X Reaction 
Buffer (50 mM PIPES, pH 7.4; 10 mM EDTA, 0.5% CHAPS), 1 M Dithiothreitol (DTT) and deionized 
water. 2X substrate working solution was then prepared by mixing Z-DEVD–R110 substrate with 
2X Reaction Buffer. Then, 2X substrate working solution was added to each sample in a black 
96-well plate and incubated for 30 minutes at room temperature, protected from the light. 
Fluorescence was measured at 485/520 nm (excitation/emission) in an ELISA plate reader (Syn-
ergy HT; Biotek). Results obtained were normalized with the corresponding DNA content and 
presented as a percentage relative to control. 
 
2.2.4.3 TRAP and ALP Activities 
ALP (osteoblast precursor cell cultures) and TRAP (PBMC cultures) were assessed at days 14 
and 21 with the p-nitrophenylphosphate (pNPP) hydrolysis assay. Briefly, osteoblast precursor 
cell and PBMC cultures were washed twice with PBS and solubilized with 0.1% (V/V) Triton X-
100 for 15 minutes. For ALP activity, osteoblast precursor cells were incubated with 22.5 mM 
pNPP prepared in 0.15 M bicarbonate buffer (pH 10.3), for 1 hour at 37ºC. For TRAP activity, 
PBMC cultures were incubated with 22.5 mM pNPP prepared in 0.225 M sodium acetate, 0.3375 
M KCl, 0,1% Tx-100, 22.5 mM sodium tartrate and 0.225 mM iron chloride (pH  5.8) for 1 hour 
at 37ºC. After incubation, the reaction was stopped with 5 M NaOH, and the absorbance of the 
samples was measured at 400 nm in an ELISA plate reader (Synergy HT; Biotek). Results were 
normalized with the corresponding DNA content and results were expressed in nmol/min/pgDNA. 
 
2.2.4.4 Number of TRAP-Positive Multinucleated Cells 
At days 14 and 21, PBMC cultures were washed twice with PBS and fixed with 3.7% formal-
dehyde for 10 minutes at room temperature. Following this, cells were stained for TRAP with 
the Acid Phosphatase, Leukocyte (TRAP) kit, according to the manufacturer’s instructions. 
Briefly, cells were incubated with 0.12 mg/mL naphthol AS-BI, in the presence of 6.76 mM 
tartrate and 0.14 mg/mL Fast Garnet GBC, for 1 hour at 37°C, in the dark. After incubation, 
cell layers were washed and stained with hematoxylin. TRAP-positive (purple/dark red) multi-
nucleated (>2 nuclei) cells were counted under an Inverted Phase Contrast microscope (Nikon 
TMS, Tokyo, Japan). 
 
2.2.4.5 Histochemical Staining of ALP and Collagen 
At days 14 and 21, osteoblast precursor cell cultures were fixed with 1.5% glutaraldehyde 
in 0.14 M sodium cacodylate buffer for 10 minutes at room temperature and, thereafter, main-
tained in sodium cacodylate buffer 0.14 M and conserved at 4ºC. For the staining of ALP, fixed 
cultures were incubated for 1 hour in the dark with a mixture, prepared in Tris buffer (pH 10), 
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containing 2 mg/mL Na-a-naphthyl phosphate and 2 mg/mL Fast Blue RR salt. The reaction was 
stopped by rinsing the samples with distilled water. A positive reaction is identified by the 
presence of a brown to black colour, in accordance with the amount of the enzyme. For the 
staining of collagen, fixed cultures were incubated with Sirus Red dye for 1 hour at room tem-
perature, and then rinsed with distilled water. Stained cultures were visualized using an In-
verted Phase Contrast microscope (Nikon TMS, Tokyo, Japan). 
 
2.2.4.6 F-actin Staining of Osteoblasts Precursor Cells 
Osteoblast precursor cell cultures, at day 21, were washed twice with PBS and after being 
fixed with 3.7% para-formaldehyde for 15 minutes at room temperature, were permeabilized 
with 0.1% (V/V) Triton X-100 for 5 minutes. Cultures were stained for F-actin with 5 U/mL Alexa 
Fluor® 647-Phalloidin (Invitrogen, Massachusetts, USA). Cultures were observed by Confocal La-
ser Scanning Microscopy (CLSM) with a Leica TCP SP2 AOBS confocal microscope (Leica, Wetzlar, 
Germany). 
 
2.2.4.7 PBMCs Displaying F-actin Rings and Expressing VNR and CTR 
PBMC cultures, at day 21, were washed twice with PBS and fixed with 3.7% para-formalde-
hyde for 15 minutes at room temperature. After fixation, cells were permeabilized with 0.1% 
(v/v) Triton X-100 for 5 minutes at room temperature. To reduce non-specific staining cells 
were incubated with 10 mg/mL bovine serum albumin (BSA) for 1 hour at room temperature 
and then stained for F-actin with 5 U/mL Alexa Fluor® 647-Phalloidin (Invitrogen, Massachusetts, 
USA), and for VNR and CTR with 50 µg/mL mouse IgGs anti-VNR and IgGs anti-CTR (R&D Systems, 
Minneapolis, USA), respectively. Detection of IgGs anti-VNR and IgGs anti-CTR was performed 
with 2mg/mL Alexa Fluor1 488-Goat anti-mouse IgGs. Cultures were observed CLSM with a Leica 
TCP SP2 AOBS confocal microscope (Leica, Wetzlar, Germany). 
 
2.2.4.8 Intracellular Signalling Mechanisms 
The osteoblastic and the osteoclastic cell responses to the lowest concentration that caused 
statistically significant inhibition of ALP or TRAP-related parameters were characterized for 
several common signalling pathways involved in osteoblastogenesis and osteoclastogenesis. For 
this purpose, PBMC and osteoblast precursor cells were treated with the corresponding com-
mercial signalling pathway inhibitor throughout the culture time. The following pathways were 
tested: MEK (methyl ethyl ketone, inhibitor U0126, 1 lM), NF-kB (nuclear factor kappa-β, inhib-
itor PDTC, 10 lM), PKC (protein kinase C, inhibitor GO6983, 5 lM), and JNK (c-Jun N-terminal 
kinase, inhibitor SP600125, 10 lM). At days 14 and 21, cultures were assessed for ALP (osteoblast 
precursor cell cultures) and TRAP (PBMC cultures) activities. 
 
2.2.4.9 Statistical analysis 
Data were obtained from three separate experiments, each one performed in triplicate. 
Results are expressed as the mean ± standard deviation. Groups of data were evaluated with a 
two-way ANOVA, and no significant differences in the patterns of cell behaviour were found. A 
two-tailed Student’s t test was performed to assess statistical differences between controls 
and experimental conditions P-values ≤ 0.05 were considered to be significant. 
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Chapter 3 
 
 
Results 
 
 
 
3.1 Osteoblastic Cell Response to Lanthanides 
 
Osteoblasts are mesenchymal origin cells that lay down the extracellular matrix and regu-
late its mineralization (Neve, Corrado, & Cantatore, 2011). During their development, osteo-
blasts display various phenotypic markers, such as high ALP activity, and synthesize several 
proteins that are associated with the mineralized matrix in vivo, including OC and OPN (A. 
Yamaguchi, Komori, & Suda, 2000a). The effect of lanthanides on osteoblast precursor cell 
cultures was evaluated, at days 14 and 21, by the assessment of the DNA content, apoptosis, 
ALP activity, histochemical staining of ALP and collagen, and F-actin staining. 
 
3.1.1 DNA Content 
An increase in cell response was observed following zinc supplementation at 10-6 M (~ 44% 
higher than control), while an opposite behaviour occurred for higher concentrations, as shown 
in Figure 3.1A. At day 21, although a statistical significance was not always reached, the same 
response pattern was observed. 
At day 14, magnesium concentrations did not affect significantly the DNA values of cell 
cultures, as observed in Figure 3.1B. At day 21, an increase in cell response was achieved in all 
tested condition (~ 6x higher than the control). 
DNA content of osteoblast cell cultures was not significantly affected by cerium at day 14, 
with the exception of the concentration of 10-3 M, which elicited a decrease in the values (~ 
29% lower than control). At day 21, only the concentrations of 10-7 and 10-4 M caused a signifi-
cant effect in cell response, increasing it by the double, compared to the control (Figure 3.1C). 
As shown in Figure 3.1D, at day 14 all lanthanum concentrations displayed an inhibitory role 
in cell response (~41% lower than control). On contrary, at day 21 all lanthanum concentrations 
elicited a marked increase of the DNA content (~ 5x higher than control). 
At day 14, praseodymium had a significant positive effect on the DNA content, with the 
maximum response being achieved at concentration of 10-6 M (~ 3x higher than the control), as 
represented in Figure 3.1E. At day 21, a similar, although not so marked effect was observed. 
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Figure 3.1 - DNA content of osteoblast precursor cells cultured in the presence of zinc, magnesium (A and 
B) and lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
 
3.1.2 Apoptosis 
At day 14 only zinc at concentration of 10-3 M had a significant effect on caspase-3 activity, 
by inducing its increase (~ 19% higher than the control), as observed in Figure 3.2A. This be-
haviour continued to be observed at day 21. Moreover, the lower concentrations started to 
affect significantly cultured cells, promoting a decrease of cell apoptosis. The maximum de-
crease was attained by zinc at 10-7 M (~ 47% lower than the control). 
Magnesium did not significantly affect apoptosis at day 14. At day 21, magnesium at 10-5 M 
promoted a caspase-3 activity decrease (~ 22% lower than the control), as observed in Figure 
3.2B. The further concentrations promoted the opposite effect, with magnesium at concentra-
tion of 10-3 M inducing the most significant rise (~ 30% higher than the control). 
Cerium did not cause significant effects in caspase-3 activity at day 14, with exception of 
concentration 10-6 M, which presented an inhibitory role (~ 13% lower than the control), as 
observed in Figure 3.2C. At day 21, all the cerium tested concentrations elicited a decrease in 
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apoptosis (~22% lower than the control), with the one exception being 10-5 M, which cause an 
increase in cell response (~18% higher than the control). 
As shown in Figure 3.2D, lanthanum at concentration of 10-6 and 10-5 M was responsible, at 
day 14, for an increase in apoptosis (~18% higher than the control). The other tested concen-
trations promoted an opposite effect (~20% lower than control). At day 21, only 10-5 M elicited 
an increase in caspase-3 activity (~16% higher than the control), while the remaining concen-
trations inhibited it (~20% lower than control).  
Praseodymium at concentrations of 10-7-10-4 M promoted a decrease of apoptosis (~ 29% 
lower than control), at day 14, as depicted in Figure 3.2E, while praseodymium at concentration 
of 10-3 M, induced the opposite influence (~ 29%). At day 21, praseodymium at 10-4 M inhibited 
caspase-3 activity (~27% lower than control), and the inverse effect was observed for 10-3 M 
(~10% higher than the control). 
 
Figure 3.2 – Caspase-3 activity of osteoblast precursor cells cultured in the presence of zinc, magnesium 
(A and B) and lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
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3.1.3 ALP activity 
At day 14, ALP activity of osteoblast precursor cells cultured in the presence of zinc was 
stimulated by all concentrations (~ 78% higher than the control), with exception of zinc at 
concentration of 10-7 M, which did not affect cell response significantly, as shown in Figure 3.3A. 
At day 21, zinc at concentration of 10-5 M induced the maximum increase of ALP activity (~ 84%), 
while the lowest concentrations tested elicited a decrease of osteoblastic marker activity (10-
4 and 10-3 M; ~ 84%).  
ALP activity was stimulated by magnesium at 10-6 -10-3 M at day 14 (~ 147% higher than 
control), whereas, only magnesium at concentration of 10-4 M improved the differentiation of 
osteoblast precursor cells at day 21 (~ 27%), as shown in Figure 3.3B. Magnesium at concentra-
tion of 10-3 M promoted a significant reduction of ALP activity (~ 97% lower than control), at 
day 21. 
As observed in Figure 3.3C, at day 14 the majority of the cerium concentrations tested, 
modulated ALP activity positively (~ 166% higher than control). At day 21, cerium at concen-
tration of 10-6 M induced the maximum response of osteoblast cells (~ 97% higher than control).  
Osteoblast differentiation was affected by lanthanum in an opposite manner at both days, 
as shown in Figure 3.3D. ALP activity of osteoblast precursor cells was stimulated at day 14 (~ 
4 times higher than the control) and inhibited at day 21 (~ 62% lower than control) by lanthanum. 
As shown in Figure 3.3E, praseodymium at 10-5-10-3 M promoted a significant increase of ALP 
activity (~ 108% higher than control) at day 14. At day 21, all concentrations tested, with ex-
ception of praseodymium at concentration of 10-6, inhibited ALP activity. 
 
Figure 3.3 – ALP activity of osteoblast precursor cells cultured in the presence of zinc, magnesium (A and 
B) and lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
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Figure 3.4 – ALP activity of osteoblast precursor cells cultured in the presence of zinc, magnesium (A and 
B) and lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
 
3.1.4 Histochemical Staining of ALP and Collagen 
Optical microscopy images from ALP activity at day 14, evaluated by histochemical staining, 
are presented in Figure 3.4. A dense monolayer organization can be observed in control (Figure 
3.4A). Supplemented cultures (Figure 3.4B and 3.4C) showed a change in the culture morphol-
ogy, with the formation of nodular structures in which grown cells converge to. A strong ALP 
staining was observed in the presented experimental conditions. 
Optical microscopy images from collagen staining assessed by histochemical staining are 
presented in Figure 3.5. In control, a homogenous cell layer is observed at day 21, staining 
positive for total collagen (Figure 3.5A). Supplementation induced a nodular organization of 
the culture, with an increased stain at the nodular structures (Figure 3.5B and 3.5C). 
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Figure 3.5 - Representative optical microscopy images of osteoblast precursor cell cultures at day 14, 
following ALP histochemical staining: (A) control, (B) magnesium at 10-4 M and (C) cerium at 10-6 M. Black 
bars represent 200 μm. 
Figure 3.6 - Representative optical microscopy images of osteoblast precursor cell cultures at day 14, 
following collagen histochemical staining: (A) control, (B) zinc at 10-5 M and (C) cerium at 10-6 M. Black 
bars represent 200 μm. 
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3.1.5 F-actin Staining of Osteoblasts Precursor Cells 
Figure 3.6 shows osteoblast precursor cell cultures at day 21, stained for F-actin visualized 
by CLSM. Cells were uniformly distributed in the wells, with visible cell-to-cell contacts, and 
displayed an expected spindle-shaped morphology. The amount of osteoblastic cells observed 
in the different conditions tested was somehow in compliance with the results obtained for ALP 
activity and staining. 
 
 
 
 
 
 
 
 
 
3.1.6 Intracellular Signalling Mechanisms 
As shown in Figure 3.7A, all the tested pathways, with exception of PKC, were involved in 
the cell response in control cell cultures, as their inhibition promoted changes in ALP activity.  
MEK pathway appeared to be involved in the cellular response developed in all conditions 
tested, with exception of magnesium and lanthanum (day 21) (Figure 3.7C and 3.7E). Moreover, 
the involvement of this pathway seemed to be more relevant in cultures performed with zinc 
and praseodymium, as observed in Figures 3.7B and 3.7F. 
ALP production by osteoblast cells in all conditions tested seemed to be negatively modu-
lated by both NFκB and JNK pathways. Moreover, the involvement of these pathways was iden‐
tical in all conditions tested. 
Although, PKC appeared to modulate the cellular response of all conditions tested, a more 
critical role of this pathway was detected in cells cultured in the presence of lanthanum, as its 
inhibition promoted an evident decrease of the enzymatic activity (Figure 3.7E). 
 
Figure 3.8 – Osteoblast precursor cells cultured with selective inhibitors of the MEK, NFκB, PKC and JNK 
signaling pathways and maintained in the absence (A) or in presence of the cations (B to F): zinc at 10-4 
M, magnesium at 10-3 M, cerium, lanthanum and praseodymium at 10-5 M. Cell responses were evaluated 
for ALP activity. * Significantly different from the control.  
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Figure 3.7 - CLSM visualisation of osteoblast precursor cell cultures at day 21, stained blue for F-actin: 
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Figure 3.9 – Osteoblast precursor cells cultured with selective inhibitors of the MEK, NFκB, PKC and JNK 
signaling pathways and maintained in the absence (A) or in presence of the cations (B to F): zinc at 10-4 
M, magnesium at 10-3 M, cerium, lanthanum and praseodymium at 10-5 M. Cell responses were evaluated 
for ALP activity. * Significantly different from the control. 
 
 
3.2 Osteoclastic Cell Response to Lanthanides 
 
Osteoclasts are ended-differentiated giant multinucleated cells of monocyte/macrophage 
lineage that are responsible for bone resorption. These bone-resorptive cells adhere and de-
grade bone matrix by secreting acid and lytic enzymes into the resorption compartment (Boyle 
et al., 2003).  Osteoclast precursors are mononucleated cells, that in contrast to early precur-
sors which do not express TRAP, are TRAP positive. In the final step of osteoclast development, 
multinucleated osteoclasts are generated by the fusion of the mononucleated precursors 
(Martin, Wah Nga, & Sims, 2013). The main phenotypic markers of osteoclasts include, along 
with TRAP expression, CTR and VNR expression (Chambers, 2000). 
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3.2.1 DNA Content 
Overall, regardless of the ion or concentration tested, it was observed a considerably de-
crease of the DNA content from day 14 to day 21 in all PBMC cultures. 
As shown in Figure 3.8A, zinc at concentrations of 10-5 and 10-4 M showed a stimulatory 
effect (~ 17% higher than the control) on the DNA content of PBMCs at day 14. At day 21, these 
concentrations continued to endorse a stimulatory effect (~ 27% higher than the control) and 
zinc at concentration of 10-7 M elicited an identical effect (~ 13% higher than the control). In 
contrast, zinc at 10-3 M induced an inhibitory effect (~ 43% lower than the control). 
As observed in Figure 3.8B, magnesium at concentrations of 10-5 - 10-3 M increased the 
amount of DNA in the PBMC cultures (~ 14% higher than the control), at day 14. At day 21, all 
the tested concentrations of magnesium affect cell response, with exception of 10-7 M. 
At day 14, only cerium at 10-5 M showed a significant effect on the DNA content of PBMC 
cultures (~ 14% higher than the control). At day 21, all cerium concentrations induced a de-
crease of DNA in the PBMC cultures, as observed in Figure 3.8C. The maximum decrease of DNA 
content was attained by the highest concentration tested (~ 49% lower than the control). 
As depicted in Figure 3.8D, the lowest concentrations of lanthanum were shown to promote 
an increase (10-7 and 10-6 M; ~ 17% higher than the control) of DNA content at day 14, while the 
highest concentration tested originated the opposite effect (10-3 M; ~ 28% lower than the con-
trol). At day 21, only the highest concentrations tested had a significant effect in cell response, 
eliciting a decrease of DNA content (10-4 and 10-3 M; ~ 41% lower than the control). 
At day 14, the DNA content of PBMC cultures was only significantly affected by praseodym-
ium at concentration of 10-5 M (~ 35% lower than the control), as demonstrated in Figure 3.8E. 
At day 21, it was observed a decrease in cell behaviour caused by all tested conditions (~ 28% 
lower than the control) 
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Figure 3.10 - DNA content of PBMCs cultured in the presence of zinc, magnesium (A and B) and lanthanides 
(C to E) at days 14 and 21 of culture. * Significantly different from the control. 
 
3.2.2 Apoptosis 
At day 14, all zinc concentrations promoted an identical increase (~ 39% higher than the 
control) of caspase-3 activity, as depicted in Figure 3.9A. In contrast, at day 21, the same 
concentrations induced a decrease in apoptosis (~ 21% higher than the control).  
As shown in Figure 3.9B, cultures performed in the presence of magnesium showed an in-
creased apoptotic response (~ 32% higher than the control). At day 21, magnesium induced a 
slight decrease of caspase-3 activity (~ 11% lower than the control) 
Cerium at concentrations of 10-7 - 10-5 M promoted the increase of apoptosis (~ 48% higher 
than the control) at day 14, in contrast the lower concentrations induced a slight decrease of 
caspase-3 activity (~ 22% lower than the control), as shown in Figure 3.9C. At day 21, all cerium 
concentrations, with exception of cerium at 10-4 M which did not affect significantly the cellular 
response, promoted a reduction of apoptosis (~ 19% lower than the control).  
At both days, lanthanum at 10-6 - 10-3 M inhibit the apoptotic response of PBMC cultures, as 
observed in Figure 3.9D. The lowest concentration tested did not significantly affect cell re-
sponse on time points.  
All praseodymium concentrations, with exception of 10-5 and 10-3 M, induced a reduction of 
apoptosis (~ 19% lower than the control), as represented in Figure 3.9E. At day 21, all concen-
trations tested inhibit the apoptotic response. The reduction was higher at the higher concen-
tration (10-3 M; ~ 27% lower than the control) and identical at the lowest concentrations (10-7 
M-10-5 M; ~ 14% lower than the control).  
 
Figure 3.11 - Caspase-3 activity of PBMCs cultured in the presence of zinc, magnesium (A and B) and 
lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
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Figure 3.12 - Caspase-3 activity of PBMCs cultured in the presence of zinc, magnesium (A and B) and 
lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
 
3.2.3 TRAP activity 
As shown in Figure 3.10A, all zinc concentrations tested, with exception of 10-3 M, stimu-
lated the differentiation of PBMCs amongst days 14 and 21 of culture, as demonstrated by the 
increase of TRAP activity comparatively to control. At day 14 the maximum response was ob-
served at concentration of 10-5 M (~ 65% higher than the control), while a more pronounced 
response at day 21 was attained at concentrations of 10-6 - 10-4 M (~ 87% higher than the control). 
Compared to the control, the concentration of 10-3 M elicited a decrease in cell behaviour at 
day 21 (~ 20% lower than the control). 
TRAP activity was increased on both days by magnesium at concentrations of 10-7 and 10-6 
M (~ 58% and ~ 69% at days 14 and 21, respectively), as shown in Figure 3.10B. Magnesium at 
10-3 M and 10-4 M inhibited the differentiation of PBMCs on day 14 (~ 68% lower than the control), 
but at day 21 they did not significantly affect cell response. 
As shown in Figure 3.10C, all cerium concentrations tested increased TRAP activity on both 
days, as observed in Figure 2C (~ 61% and 125% at days 14 and 21, respectively). 
As shown in Figure 3.10D, on both days lanthanum significantly stimulated the differentia-
tion of PBMCs at the lowest concentrations tested (10-7 and 10-6 M; ~ 72% and ~ 63% at days 14 
and 21, respectively), while the highest concentrations inhibited the differentiation (10-4 and 
10-3 M; ~ 57% and ~ 63% at days 14 and 21, respectively). At day 21, the maximum response was 
achieved at a lanthanum concentration of 10-5 M (~ 97%). 
At day 14, praseodymium at 10-7-10-6 M promoted a significant increase of TRAP activity (~ 
78%), whereas a decrease of the osteoclastic marker activity was elicited by the highest con-
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centrations tested (10-4 and 10-3 M; ~ 30%), as shown in Figure 3.10E. This behaviour was main-
tained at day 21, though with more pronounced differences, when compared with the control 
(~ 140% increase for 10-7-10-5 M; ~44% decrease for 10-4 and 10-3 M). 
 
Figure 3.13 - TRAP activity of PBMCs cultured in the presence of zinc, magnesium (A and B) and lantha-
nides (C to E) at days 14 and 21 of culture. * Significantly different from the control. 
 
3.2.4 Number of TRAP-Positive Multinucleated Cells 
TRAP-positive multinucleated cells were formed in PBMCs cultures in the presence of zinc 
(Figure 3.11A). As observed for TRAP activity, at day 14 the maximum response was attained 
by zinc at concentration of 10-5 M (~ 97% higher than the control). At day 21 a more marked 
response was induced by zinc at 10-6 - 10-4 M (~ 58%). 
In the presence of magnesium, TRAP-positive multinucleated cells formation was stimulated 
on both days by magnesium at concentrations of 10-7 - 10-5 M (~ 37% and ~ 21% at days 14 and 
21, respectively), as observed in Figure 3.11B. Moreover, magnesium at concentrations of 10-4 
and 10-3 M, inhibited the formation of TRAP-positive multinucleated cells on both days (~ 88%). 
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At day 14, cerium at 10-7 - 10-5 M prompted the formation of TRAP-positive multinucleated 
cells (~ 14% higher than the control), as represented in Figure 3.11C. At day 21, the majority 
of cerium concentrations promoted TRAP-positive multinucleated cells formation. The maxi-
mum response was induced by cerium at 10-5 M (~ 91% higher than the control).  
As shown in Figure 3.11D, on both days lanthanum significantly stimulated the formation of 
TRAP-positive multinucleated cells at the lowest concentrations tested (10-7 and 10-6 M; ~ 43% 
and ~ 56% at days 14 and 21, respectively), while the highest concentrations inhibited the dif-
ferentiation (10-4 and 10-3 M; ~ 89% and ~ 92% at days 14 and 21, respectively). 
At day 14, praseodymium at concentrations of 10-7 and 10-6 M promoted a significant in-
crease of TRAP-positive multinucleated cells formation (~ 53% higher than control), as shown in 
Figure 3.11E. As observed, at day 21, praseodymium at 10-4 and 10-3 M played an inhibitory role 
(~ 41% lower than control).  
 
Figure 3.14 – Number of TRAP-positive multinucleated cells on PBMC cultures: in the presence of zinc, 
magnesium (A and B) and lanthanides (C to E) at days 14 and 21 of culture. * Significantly different from 
the control. 
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3.2.5 PBMCs Displaying F-actin Rings and Expressing VNR and CTR 
Representative CLSM images of PBMC cultures, stained blue for F-actin and green for VNR 
and CTR, at day 21, are shown in Figure 3.12. Cells displayed well-defined F-actin rings and 
positive staining for VNR and CTR in all tested conditions. The amount of PBMCs in the different 
conditions was somehow correlated with the results observed for TRAP activity and staining, 
that means, the presence of zinc and lanthanum (10-6M and 10-5M, respectively) increased the 
amount of osteoclastic cells in culture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.6 Intracellular Signalling Mechanisms 
In PBMC cultures maintained in control conditions (Figure 3.13A), all the tested pathways 
were involved in the cell response, but NFκB was essential, as its inhibition completely abol‐
ished TRAP synthesis. 
The involvement of MEK pathway in PBMC development appeared not to modulate TRAP 
activity of cells cultured in the presence of lanthanum (day 21), while in the presence of the 
zinc, magnesium and the remaining lanthanides, it seemed to have a high relevance in the 
process. 
 NFκB seemed to play the most critical role in the cell response, in the different conditions 
tested (Figures 3.13B-3.13F).  
170 µm 170 µm 
170 µm 170 µm 
170 µm 170 µm 
A B 
C D 
E F 
Vitronectin Receptors Calcitonin Receptors 
Figure 3.15 - CLSM visualisation of PBMC cultures at day 21, stained blue for F-actin and green for VNR 
and CTR: control (A and B), zinc at 10-6 M (C and D) and lanthanum at 10-5 M (E and F). White bars represent 
170 μm. 
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JNK was not significantly involved in the response of cells cultured in the presence of zinc, 
magnesium (day 21) and cerium, as observed in Figures 13.3B, 13.3C and 13.3D.  In the remain-
ing conditions, JNK appeared to have a relevant role in osteoclastogenesis, as shown in Figures 
13.3E and 13.3F. 
 PKC showed to be very important in all tested conditions, particularly in cell cultures per-
formed in the presence of praseodymium, as demonstrated in Figure 13.3F. 
 
  
  
 
Figure 3.16 - PBMCs cultured with selective inhibitors of the MEK, NFκB, PKC and JNK signaling 
pathways and maintained in the absence (A) or in presence of the cations (B to F): zinc at 10-4 M, 
mag-nesium at 10-3 M, cerium, lanthanum and praseodymium at 10-5 M. Cell responses were evaluated 
for TRAP activity. * Significantly different from the control 
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Figure 3.17 - PBMCs cultured with selective inhibitors of the MEK, NFκB, PKC and JNK signaling pathways 
and maintained in the absence (A) or in presence of the cations (B to F): zinc at 10-4 M, mag-nesium at 
10-3 M, cerium, lanthanum and praseodymium at 10-5 M. Cell responses were evaluated for TRAP activity. 
* Significantly different from the control 
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Chapter 4 
 
 
Discussion 
 
 
 
4.1 Overview 
 
Bone is a specialized and dynamic organ that undergoes a continuous remodeling throughout 
life (Clarke, 2008). Its structure and metabolic activity may become compromised by any im-
balance between bone formation and resorption, which depend on osteoblasts and osteoclasts, 
respectively (Wróbel & Witkowska-Zimny, 2013).  
Lanthanides are a group of metal ions with similar properties, which have been known for 
their diversity of biological effects and of great potential in medical applications (K. Wang et 
al., 1999). Lanthanides have been shown to functionally mimic calcium, as they possess analo-
gous chemical characteristics, namely, ionic radii, donor atom preferences and coordination 
numbers (Fricker, 2006; Sastri et al., 2003). Due to these similarities, lanthanides can exchange 
with calcium in bone and, consequently, affect the remodeling cycle, by modulating osteoblast 
and osteoclast differentiation and function (Barta et al., 2007; Pidcock & Moore, 2001; Webster, 
Massa-Schlueter, Smith, & Slamovich, 2004).  
Due to these characteristics, lanthanides attracted much attention in recent years and be-
came the focus of interest for the synthesis of bone related biomaterials (Aissa et al., 2009). 
In this context, the activation and metabolic activity of osteoblast-like cell lines (HOS TE 85) 
on samarium oxide surfaces was reported. These cells displayed a normal morphology and 
growth, expressed ALP and osteocalcin and presented a slight increased proliferation compar-
atively to controls (Herath, Di Silvio, & Evans, 2010). In another work, Webster et al. doped 
HAp with various metal cations (such as, Mg2+, Zn2+, La3+, Y3+) in an attempt to enhance Hap 
properties, relevant for orthopaedic and dental applications. The results obtained indicated 
that human osteoblasts adhered and differentiated in response to HAp doped with trivalent 
cations at earlier time points than with HAp doped with divalent cations or undoped Hap 
(Webster et al., 2004). 
Apart from these studies, more classical approaches related to the effect of lanthanides on 
bone cells in vitro were also performed by several authors. Wang et al reported that ALP activ-
ity of primary mouse osteoblasts was enhanced by lanthanum (10-8 to 10-5 M) after two days in 
culture and inhibited by the same range of concentrations after seven days in culture (X. Wang 
et al., 2008). Yttrium effect on primary mouse osteoblasts was also investigated. The results 
showed that yttrium inhibited the differentiation of osteoblasts at tested concentrations (10-9 
to 10-4 M) at day 2 and that the lower concentrations (10-9 to 10-7 M) inhibited the differentiation 
at day 3. Moreover, tested concentrations showed to promote osteoblast proliferation at days 
1, 2 and 3 (J. Zhang  et al., 2010). 
The influence of lanthanides on bone resorbing function of osteoclasts was also reported, 
although in a less extent than on osteoblasts. Zhang et al. investigated the effect of several 
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lanthanides by culturing Japanese white rabbit osteoclasts on bone slices. The number of oste-
oclasts and the surface areas of the lacunae indicated that lanthanum, samarium, erbium (10-
7, 10-6 and 10-5 M), neodymium, gadolinium and dysprosium (10-6 and 10-5 M) inhibited osteoclas-
tic activity (J. Zhang  et al., 2003). Zhang et al. also analysed the effect of lanthanum (10-8 to 
10-5 M) on the bone resorbing activity of rabbit mature osteoclasts co-cultured with osteoblasts. 
The results demonstrated that after 20 days in culture, osteoclasts started to spread and adhere 
different morphologies. Moreover, histochemical staining of TRAP revealed red deposits located 
in the cytoplasm. The authors suggested that in addition to osteoblast-osteoclast contact, lan-
thanum was also required to produce a change in the resorbing activity of osteoclasts (J. Zhang  
et al., 2005).  
Although the effect of lanthanides on mouse/rabbit bone cells had already been somehow 
described in several studies, to the best of our knowledge few reports focused on the effect of 
lanthanides on human bone cells. Therefore, in the present study, cultures of human osteoclas-
tic and osteoblastic precursor cells were used as in vitro models to address the cellular and 
molecular effects of lanthanides (lanthanum, cerium and praseodymium) at different concen-
trations (10-7 to 10-3 M) on osteoblast and osteoclast development. Zinc and magnesium were 
used as reference physiological cations, since the effect of these elements on bone cells dif-
ferentiation is already well-established. 
Osteoblast and osteoclast differentiation are controlled by complex activities involving sev-
eral signalling pathways and transcriptional regulators (Datta et al., 2008). The intracellular 
signalling pathways involved in the cellular response induced by lanthanides has not been well-
explored so far. Accordingly, to gain insight into the intracellular events that modulate osteo-
blast and osteoclast behaviour in the presence of lanthanides, several important signalling 
pathways involved in osteoblastogenesis and osteoclastogenesis were characterized in the pre-
sent study. 
 
4.2 Osteoblastic Cell Response to Lanthanides 
 
During the differentiation of osteoblast precursor cells into osteoblasts, cells undergoes 
DNA synthesis and cell division, resulting in a rapid increase in cell number until confluence 
(Bellows, Aubin et al. 1991). The rate of DNA synthesis is known to vary in coordination with 
the rate of cell proliferation (Rubin, 2005). Accordingly, the effect of lanthanides on cell pro-
liferation was evaluated by quantifying the total amount of double-stranded DNA through the 
culture time.  
The results of the DNA content showed that, although a statistical significance was not 
always reached, the lowest concentrations of zinc increased DNA synthesis while the highest 
concentrations endorsed the opposite behaviour. The positive influence of zinc in bone for-
mation was proposed to be in part related with bone protein synthesis, since stimulatory effect 
of zinc compound on DNA synthesis in osteoblastic cells is completely abolished when cells are 
cultured with inhibitors of protein synthesis (Hashizume & Yamaguchi, 1993). The effect of zinc 
on DNA synthesis was previously investigated in osteoblastic MC3T3-E1 cells. In one of the works, 
cells were cultured with a zinc compound, namely zinc sulfate, in a range of concentrations of 
10-7 to10-5 M, for 72 hours. The results showed that zinc sulfate at concentration of 10-5 M pro-
duced a significant increase of cell number, DNA content, and protein concentration (M. 
Yamaguchi & Matsui, 1996). In another work, cells were cultured and treated with various con-
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centrations of zinc (1, 3, 15, 25 uM) for 1, 5 and 10 days. The results showed that cell prolifer-
ation was stimulated at low zinc concentration (1-3 µM) at day 1. Furthermore, zinc-stimulated 
cell proliferation was more prominent at 15 and 25 uM at days 5 and 10 (Seo, Cho, Kim, Shin, 
& Kwun, 2010).  
All concentrations of magnesium showed a positive effect on the DNA content of osteoblast 
precursor cells at day 21, although a less pronounced effect was denoted at the lowest concen-
trations. These results were not surprising, since magnesium is required for cell proliferation. 
Low magnesium concentrations is known to reduce  protein synthesis, which is followed by a 
large reduction in the rate of DNA synthesis (Rubin, 2005). The effect of magnesium on DNA 
synthesis of osteoblast precursor cells was previously assessed on human osteoblast-like MG-63. 
In these study cells were incubated in the presence of different concentrations of both calcium 
(0.1 and 1 mM) and magnesium (0.01, 0.1, 0.4 and 0.8 mM) for 24 and 48 hours. DNA synthesis 
was significantly decreased at both time points under culture conditions of magnesium below 
0.8 mM, at all concentrations of calcium (Abed & Moreau, 2007). Thus, it is observed a discrep-
ancy between the results obtained in the present study and those obtained by Abed and Moreau. 
This difference could be explained by the different cells tested in both studies, and by the use 
of calcium in their experiment. Magnesium is commonly noted as a calcium antagonist, there-
fore, these two elements are often linked and can compete with each other for the same re-
ceptors (Jahnen-Dechent & Ketteler, 2012). Accordingly, the competition between the two el-
ements could be responsible by the loss of magnesium effect. Moreover, the different time 
points used may also be responsible for the differences founded. 
The DNA synthesis in osteoblast precursor cells was shown to be inhibited at day 14 by 
cerium at concentration of 10-3 M and promoted at day 21 by 10-7 and 10-4 M. The remaining 
concentrations tested did not elicited a statistical significant cell response, however, by ana-
lysing the qualitative behaviour of the cultures it was possible to verified that all conditions, 
with exception of 10-3 M at day 14, promoted an identical or slightly increased response com-
pared to control at both days. Therefore, cerium apparently did not influence negatively the 
proliferation of osteoblast precursor cells, regardless of the concentration used. The effect of 
cerium (10-9 to 10-4 M) on the proliferation of primary mouse osteoblasts was already described 
by Zhang et al. The authors demonstrated that all concentrations tested promoted the prolif-
eration of cells at days 1, 2 and 3. Moreover, the highest concentration of cerium tested (10 -4 
M) has been shown to promote the maximum effect at all the culture days. 
Lanthanum-induced DNA synthesis presented an opposite response pattern at both time 
points analysed. At day 14 all concentrations tested reduced osteoblast precursor cells prolif-
eration, whereas, an increased proliferation was attained by all concentrations at day 21. The 
present finding suggests a gradual effect of lanthanum on osteoblast proliferation. Apparently, 
cells need to adapt to lanthanum before the increase of DNA content becomes evident. This 
gradual response has already been described in osteoblasts, isolated from Sprague-Dawley fetal 
neonatal rats, cultured in the presence of lanthanum at a range of concentrations of 10-8 to10-
4 M. After incubation of osteoblasts with lanthanum for 1 day, only lanthanum at 10-6 M showed 
a positive effect on the cell proliferation. However, all concentrations significantly increased 
cell number after two days (X. Wang, Huang, Zhang, & Wang, 2009).  
All concentrations of praseodymium tested increased DNA content at both time points, 
though with a less pronounced response at day 21. These results may suggest that, although 
praseodymium affects positively cell proliferation, over time this effect is lost. As far as we 
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know, the influence of praseodymium on osteoblast proliferation has not been described here-
tofore.  
Apoptosis is a highly organized process characterized by the progressive activation of pre-
cise pathways leading to specific biochemical and morphological alterations (Franco, DeHaven, 
Sifre, Bortner, & Cidlowski, 2008). Cell selection by apoptosis occurs during normal physiologi-
cal functions as well as diseases (Corcoran et al., 1994). Besides, it has been recognized that 
many of the toxic effects are mediated by regulation/induction of apoptosis (Franco, Sánchez-
Olea, Reyes-Reyes, & Panayiotidis, 2009). Aside from promoting cell proliferation, lanthanides 
have been also shown to induce apoptosis (Shen et al., 2010). Lanthanide induced-apoptosis 
has been described in several cell types, namely, rat skin fibroblasts, HeLa and PC12 cells (K. 
Wang et al., 2003). Only a few reports described the effect of lanthanides on bone cell apop-
tosis. 
Apoptosis results of cultures performed in the presence of zinc showed a concentration-
dependent increase, at day 21. The maximum apoptotic response was attained, at both days, 
by zinc at concentration of 10-3 M, which suggests that this concentration may have a toxic 
effect on osteoblast precursor cells, a value significantly higher than the physiological levels of 
zinc in human serum (10.1 µM to 16.8 µM) The increased apoptotic response at the higher 
concentrations is in line with the observed decrease of the DNA content. 
Osteoblast precursor cells culture in the presence of magnesium at concentration of 10-5 M 
showed a slightly lower caspase-3 activity. This result is in agreement with the results of the 
DNA content, since magnesium at 10-5 M was shown to induce a more pronounced DNA synthesis. 
The remaining conditions tested induced an increase in apoptosis. 
Cultures performed in the presence of cerium and lanthanum presented an identical apop-
totic profile. In both cases, an increased apoptotic response was induced by both lanthanides 
at 10-5 M (cerium at day 14 and lanthanum at days 7 and 14). Moreover, a decrease in caspase-
3 activity induced by both the lowest and the highest concentrations was detected in the two 
conditions By comparing the results of the two lanthanides at concentration of 10-5 M was ob-
served a slightly higher response when cells were cultured with cerium. This suggests that ce-
rium presents a more toxic effect than lanthanum. This issue was already stated with male 
Sprague-Dawley rat pulmonary alveolar macrophages, exposed to cerium, lanthanum, and ne-
odymium for 20 hours. The results showed that cerium was highly cytotoxic, followed by lan-
thanum, whereas neodymium showed only a slight reduction of viability (Palmer, Butenhoff, & 
Stevens, 1987).  
Cells cultured in the presence of praseodymium showed an increased caspase-3 activity at 
both days at concentration of 10-3 M, nevertheless, the response promoted by this concentration 
was less pronounced at day 21. Moreover, it was verified that all concentrations tested (with 
exception of 10-3 M) inhibited apoptosis at day 14, while, a similar response to control was 
attained by these concentrations at day 21 (although a statistical significance was not reached). 
Praseodymium has been previously found to be toxic to human cells, such as, osteosarcoma 
cells, umbilical cord perivascular cells, causing their apoptosis (Polis et al., 2013).  
Osteoblast differentiation plays a critical role in bone formation and remodeling. At a mo-
lecular level, it is considered that an increase of ALP activity is related to the transition from 
an earlier to a more mature stage of osteoblast differentiation (Stein & Lian, 1993). Thus, as 
one of the most widely recognised biochemical markers of osteoblastic activity, ALP activity 
was used in the present work to assess the ability of lanthanides to modulate osteoblast pre-
cursor cells differentiation (Seo et al., 2010).  
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ALP synthesis was highly stimulated by zinc at concentration of 10-5 M at day 21, while the 
highest concentrations tested appeared to prevent cell differentiation. The ability of zinc to 
stimulate ALP activity in a concentration-dependent manner was already reported in previous 
works, where mouse osteoblastic MC3T3-E1 showed an increased ALP activity pattern upon zinc 
treatment (1, 3, 15, 25 uM) (Seo et al., 2010; M. Yamaguchi, 1998; M. Yamaguchi & Yamaguchi, 
1986).  
It was observed, at day 21, that while magnesium at 10-4 M induced a statistical significant 
increase of osteoblast differentiation, magnesium at 10-3 M elicited the opposite effect. In line 
with this, it was previously reported that high concentrations of magnesium (5 mM) caused an 
inhibition of ALP activity in human osteoblasts (Leidi, Dellera, Mariotti, & Maier, 2011).  
Cerium promoted the differentiation of osteoblasts precursor cells at most concentrations 
tested, except at higher concentrations, where it displayed an opposite effect. These results 
are accordant with previous reports, where cerium at concentrations of 10-9 to 10-6 M promoted 
mouse osteoblasts differentiation and at higher concentrations (10-5 and 10-4 M) inhibited the 
differentiation (J. Zhang et al., 2010).  
Lanthanum showed a concentration- and time-dependent effect on ALP activity of osteo-
blasts precursor cells. At day 14 all lanthanum concentration enhanced osteoblast precursor 
cells differentiation, while an inhibitory effect was observed in the whole range of concentra-
tions at day 21. This behaviour pattern is in agreement with previously data described by Wang 
and his co-workers with osteoblasts derived from rats that were cultured in the presence of 
lanthanum (10-8 M to 10-4 M) for 24, 48 and 72 hours) (X. Wang et al., 2008). The results of the 
DNA content and ALP activity of cells cultured revealed an inverse relationship between cell 
proliferation and differentiation, as expected as a general cell behaviour. 
ALP activity of the cultures performed in the presence of praseodymium revealed a small 
ability to induce osteoblast precursor cells differentiation at day 14. This behaviour continued 
to be observed at day 21, as all concentrations tested inhibited ALP synthesis. These results 
are somehow related to the results obtained previously. Zhang et al. investigated short-term 
effects of PrCl3 on the differentiation of primary mouse osteoblasts. In this work, PrCl3 (10
-8 M 
to 10-4 M) was shown to inhibit osteoblast differentiation for 36 hours. Similarly to lanthanum, 
it was observed that praseodymium had a negative effect on cell differentiation but induced 
cell proliferation.  
Collagen synthesis as an also well-recognized biochemical marker of osteoblastic differen-
tiation, was assessed by histochemical staining (Seo et al., 2010). As mentioned previously, the 
presence of mature osteoblasts is indicated by the production of ALP which in turn interacts 
with collagen during matrix mineralization (Linder, Enander, & Magnusson, 2014). Although, 
these results are qualitative it was observed a close relation between ALP activity and collagen 
staining. In fact, it was observed that the conditions that induced a more pronounced ALP 
synthesis, presented a more marked staining for collagen, suggesting a higher degree of osteoid 
production. Moreover, these conditions induced a nodular organization of the culture, with an 
increased stain at the nodular structures.  
As mentioned above, osteoblast precursor cell cultures were also tested for the involvement 
of several signalling pathways (MEK, NFkB, JNK and PKC). Some significant alterations on the 
contribution of the tested pathways on the response of osteoblastic cells were observed. MEK 
pathway appeared not to be involved in the cellular response performed in the presence of 
magnesium and lanthanum. Although, this pathway seemed to the involved in the remaining 
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conditions, a more relevant role was observed in cultures performed with zinc and praseodym-
ium. This result contrasts with a previous study that showed that lanthanum enhances the in 
vitro differentiation of osteoblast derived from Sprague-Dawley rats via ERK signalling pathway 
(Wang, Yuan, Huang, Zhang, & Wang, 2008). NFκB and JNK pathways seemed to be involved in 
all tested conditions which suggests that these pathways could be important targets of lantha-
nides on osteoblast precursor cells. Lanthanum chloride has been previously demonstrated to 
enhance osteoblastic differentiation and apoptosis by supressing the activation of JNK (Li et 
al., 2009). PKC appeared to modulate the cellular response in all conditions tested, although a 
more critical role of this pathway was detected in cells cultured in the presence of lanthanum, 
as its inhibition promoted an evident decrease of the enzymatic activity. 
 
 
4.3 Osteoclastic Cell Response to Lanthanides 
 
Next, the effect of lanthanides on PBMC cultures was evaluated. As mentioned previously, 
even though the effect of lanthanides on osteoclasts formation, differentiation and activity has 
already been addressed, the number of reports is rather low compared to osteoblasts.  
Osteoclasts are large multinucleated cells formed by the fusion of mononuclear progenitors 
of the monocyte–macrophage lineage (Hoebertz & Arnett, 2003). A number of studies have 
shown that RANKL and M-CSF are necessary and sufficient to promote osteoclastogenesis (Boyle 
et al., 2003). Osteoclast differentiation is characterized by acquisition of mature phenotypic 
markers, such as the CTR, VNR, TRAP, integrin αvβ3, morphological conversion into large mul-
tinucleated cells and the capacity to form resorption lacunae on bone (Lacey et al., 1998). 
While physiological osteoclastic bone resorption is essential for the maintenance of human skel-
eton, enhanced osteoclast formation and/or function result in excessive bone resorption, lead-
ing to either localized osteolysis or systemic bone loss (Ying et al., 2015).  
To evaluate the effect of the different ions and concentrations tested on the density of 
PBMCs, DNA content was measured after 14 and 21 days of culture. Overall, regardless of the 
ion or concentration tested, it was observed a reduction in the DNA content from day 14 to day 
21, which was expected, since the first osteoclastogenic steps involve fusion of the precursor 
cells.  
The DNA content of PBMCs cultured in the presence of zinc appeared to be decreased at 
the highest concentration tested. A similar finding was already described in mouse bone mar-
row-derived monocyte cells cultured in the presence of ZnSO4 (1, 10, 30, 60 and 100 µM) for 4 
days. In this work, it was identified a dose-dependent inhibition of osteoclast formation upon 
zinc treatment (Park et al., 2013).  
With regard to PBMCs cultured in the presence of magnesium, it was observed that the 
amount of DNA at day 21 was up-regulated by the lowest concentrations and down-regulated 
by the highest concentrations tested, though the influence observed was not particularly high. 
The role of magnesium at different concentrations (0.08, 0.4 and 0.8 mM), was previously eval-
uated using osteoclast precursor cells isolated from long bones and jaws from mice. Notwith-
standing, the results did not show any differences in the DNA amount, between day 3 and 6 
(Belluci et al., 2013). 
All concentrations of cerium and praseodymium induced a decrease of the DNA synthesis by 
PBMC cultures at day 21, while at day 14 almost no difference was observed comparatively to 
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control. This may suggest that both lanthanides are able to modulate PBMCs density in a con-
centration independent-manner, however, the effect is only observed over time. 
Lanthanum at the lowest concentrations tested showed a stimulatory effect on the DNA 
content at day 14, however, the effect seemed to be lost over time. It was also observed that 
although the highest concentrations tested had induce a slight decrease of the DNA content at 
day 14, at day 21 the effect had become more evident and statistical significant. These out-
comes may suggest a time- and concentration- influence of lanthanum on cell density. 
Osteoclast apoptosis is an important point of control of bone resorption, since after per-
forming their resorption activity, osteoclasts undergo apoptosis. Decreased osteoclast apoptosis 
is in general associated to an increased bone loss (Xing & Boyce, 2005). Hence, the regulation 
of the numbers of osteoclast precursors and mature osteoclasts via the induction of cell death 
may be a mechanism by which the number of active osteoclasts at any site is controlled, thus, 
allowing to control bone resorption (Roux & Brown, 2009). In order to assess the ability of the 
lanthanides to induce PBMCs apoptosis, caspase-3 activity was quantified at day 14 and 21.  
It was observed an overall increase of apoptosis between day 14 and 21, regardless of the 
ion or concentration tested. These outcome could be also related to the reduction of the DNA 
content observed between the two time points. Apoptosis is defined by morphological changes 
of cells and nuclei, such as cell shrinkage, condensation and fragmentation of nuclei, and 
blebbing of the plasma membranes. Moreover, this event is often accompanied by degradation 
of chromosomal DNA, which could explain the observed phenomenon  (Nagata, Nagase, Kawane, 
Mukae, & Fukuyama, 2003). 
All zinc concentrations tested induced a higher apoptotic response at day 14. At day 21, 
the effect was opposite to the observed at day 14, however, the difference relatively to control 
(although statistical significant) was low. These results may indicate an ability of zinc to up-
regulate osteoclast apoptosis, although the effect may be attenuate or lost over time. Likewise, 
the ability of zinc to induce apoptosis was previously described in osteoclast precursor from 
mice, where zinc at 10-5 M in the presence or absence of M-CSF and RANKL for 24 or 72 hours 
was shown to cause a significant increase in caspase-3 mRNA expression in osteoclastic cells (A. 
Yamaguchi & Uchiyama, 2008). 
At day 14 cultures performed in the presence of magnesium showed an increased apoptotic 
response. On the other hand, at day 21, magnesium induced a very slight decrease of caspase-
3 activity. These results may indicate that after cells being adapted to the presence of the 
magnesium ions, the apoptotic response is lowered to a level similar to control. Moreover, a 
study on the effect of magnesium on mature osteoclasts, showed that magnesium ions in the 
culture medium did not increase osteoclast apoptosis even at 100 ppm (Li, Senda, Ito, Sogo, & 
Yamazaki, 2008).  
Cerium induced apoptosis at the lowest concentrations tested and inhibited this response 
at the highest concentrations, at day 14. The response induced by the highest concentrations 
was maintained at day 21, whereas the lowest concentrations started to present an inhibitory 
effect. This results may express the ability of cerium to act as a negative-modulator of osteo-
clast apoptosis.  
Lanthanum and praseodymium presented an inhibitory effect on the apoptotic response at 
both days. These findings may suggest that both ions modulate apoptosis negatively, in a con-
centration- and time-independent manner. 
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TRAP is an enzyme highly expressed in both immature and mature osteoclasts (Fuchs et al., 
2009). Therefore, in order to evaluate the ability of lanthanides to induce PBMCs differentiation, 
TRAP activity and the number of TRAP positive multinucleated cells were assessed. 
All zinc concentrations, with exception of 10-3 M, presented a stimulatory effect on TRAP 
activity. Zinc has been associated to the reduction of bone loss by supressing osteoclast differ-
entiation. However, it was also reported that this ability is concentration-dependent. As matter 
of fact, TRAP activity of primary cultured mouse BMMs was shown to be inhibited by all ZnSO4 
concentrations tested (1, 10, 30, 60, 100 µM), yet, a more pronounced inhibition was observed 
at 100 µM (Park et al., 2013). These observations could indicate that although zinc is able to 
reduce the differentiation of PBMCs, this ability is only observed at high concentrations. The 
results concerning the number of TRAP positive multinucleated cells also showed a decrease of 
fused multinucleated osteoclasts by zinc at 10-3 M. Since it was observed that this concentration 
did not induced an apoptotic response (at day 21), this could indicate that the inhibitory effect 
of zinc on PBMCs differentiation was not caused by zinc toxicity. 
Magnesium at the lowest concentrations tested increased PBMCs differentiation on both 
time points. The highest concentrations tested presented an inhibitory effect at day 14. The 
inhibitory role was lost at day 21, even so, these concentrations were not able to induce a 
significant increase of TRAP activity. These results may suggest a positive effect of all magne-
sium concentrations tested at long term. A former work seemed to support this outcome, 
namely, Wu et al. indicated that MgCl2 first enhanced and then opposed PBMCs differentiation 
in a concentration-dependent manner (peaking between 10 and 15 mM) at day 28 (Wu, 
Luthringer, Feyerabend, Schilling, & Willumeit, 2014). In accordance with these elements, the 
magnesium concentrations tested in the present work seemed to be too low to observe a de-
crease of PBMCs differentiation caused by the concentration.  
Considering the results regarding TRAP activity and the number of TRAP positive multinu-
cleated cells, it appeared that all cerium concentrations stimulate PBMCs differentiation. These 
results are somehow related to the low apoptotic response (day 21) observed. 
Lanthanum induced a similar response at both days, with the lowest concentrations pre-
senting a stimulatory effect on PBMCs differentiation and the highest concentrations presenting 
the opposite influence. The same effect was already described in the DNA content whereas 
apoptosis appeared not to be influenced by lanthanum concentration. Therefore, the ability of 
lanthanum to reduce PBMCs differentiation at the highest concentrations was not related to 
lanthanum toxicity.  
The effect of praseodymium on PBMCs differentiation was similar to lanthanum, the lowest 
concentrations induced PBMCs differentiation while the highest concentrations inhibited it. 
Moreover, by analysing the apoptosis results it was also observed that the inhibitory effect 
caused by the highest concentrations was not related to praseodymium toxicity.  
Confocal images of PBMCs were in line with the previous results, that is, the conditions that 
elicited PBMCs proliferation and differentiation presented an increased amount of osteoclastic 
cells in culture displaying osteoclast phenotypic features (VNR and CTR). 
The involvement of the signalling pathways (MEK, NFkB, JNK and PKC) on PBMCs response 
was also evaluated. NFkB pathway seemed to be crucial in all tested conditions, which strongly 
suggests that, in our culture conditions, this can be a major osteoclastogenic intracellular 
mechanism. JNK pathway did not contribute to the cellular response of PBMC cultured in the 
presence of zinc, magnesium and cerium, whereas in the presence of lanthanum appeared to 
have a relevant role. PKC showed to be very important in all tested conditions, particularly in 
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cell cultures performed in the presence of praseodymium. MEK pathway appeared not to mod-
ulate TRAP activity of cells cultured in the presence of lanthanum. 
 
 
4.4 General Discussion 
 
Everything considered, lanthanides seemed to be able to affect human osteoclastic and 
osteoblastic proliferation and/or differentiation. Moreover, it was observed that the concen-
tration and culture time were critical factors for switching the biological effects of lanthanides 
from toxicity to activity or from down-regulation to up-regulation, an outcome already stated 
previously (K. Wang et al., 2003). 
As already stated in previous works, it was observed that zinc contributes to the enhance-
ment of osteoblast proliferation. This influence was only annulled at the highest concentrations 
tested, probably due to a toxic effect generated by this range of concentrations. Furthermore, 
ALP synthesis was also down-regulated by the highest concentrations. Osteoclast density and 
differentiation was affected by zinc in a way similar to osteoblast.  
Magnesium was also shown to promote osteoblast proliferation. All the concentration range 
produced an up-regulation of proliferation, while, only magnesium at concentration of 10-4 M 
induced an increased differentiation. Osteoclast density was increased by the lowest concen-
trations of magnesium and inhibited by the highest at day 21. However, at day 21, all the 
concentrations tested exhibited an identical ability to induce cell differentiation.  
Overall, cerium in the majority of the concentrations tested appeared not to affect osteo-
blast significantly proliferation. Additionally, it was observed that cerium at the lowest con-
centrations was able to induce osteoblast differentiation and that this effect was lost at the 
highest concentrations. In contrast, cerium was able to modulate osteoclast density at least at 
day 21. Additionally, it was observed that osteoclast differentiation was increased by cerium 
at both days, with suggests a strong ability of these lanthanide to promote this response. 
Lanthanum inhibited osteoblast proliferation in all concentration range at day 14, whereas, 
the opposite effect was displayed at day 21. Moreover, lanthanum has shown to be unable to 
induce osteoblast differentiation at day 21. Osteoclast density appeared to be up-regulated by 
lanthanum at the lowest concentrations, still, this effect seemed to be lost over time. Even 
thought, the highest concentrations exhibited the opposite influence, this effect only became 
evident at day 21. Osteoclast differentiation was inhibited by the highest concentrations of 
lanthanum at both days.  
Praseodymium was shown, at both time points, to up-regulate DNA synthesis at all concen-
tration tested, which suggest that this cation is able to modulate positively osteoblast prolifer-
ation regardless of the concentration tested. On contrary, it showed to be a negative regulator 
of osteoblast differentiation. Osteoclast density was down-regulated by praseodymium in all 
concentrations tested, even though the effect was only detected at day 21. Praseodymium was 
shown to inhibit osteoclast differentiation at the highest concentrations. Therefore, praseo-
dymium appeared to act as negative regulator of osteoclast density, however, only down-reg-
ulates their differentiation at the highest concentrations. 
To sum up, it was observed that both lanthanum and praseodymium were able to modulate 
osteoblast proliferation, nevertheless, only praseodymium presented a stimulatory effect on 
both days. Osteoblast differentiation was modulated by all the lanthanides tested, even thought, 
only cerium was able to enhance differentiation at day 21. The results concerning the osteoclast 
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cultures showed a reduction in the DNA content, regardless of the ions or concentration tested. 
Moreover, it was observed that while lanthanum induced this influence only at the highest 
concentrations, cerium and praseodymium were able to induce this response in all the concen-
tration range. Osteoclast differentiation was also shown to be regulated by cerium, lanthanum 
and praseodymium. Moreover, it was noted that, while cerium acted as positive regulator of 
osteoclast differentiation in a concentration-independent manner, lanthanum and praseodym-
ium acted as positive or negative-regulators of osteoclast differentiation depending on their 
concentration.  
Although the effect of lanthanides on osteoblast and osteoclast proliferation and differen-
tiation was closely related to the concentration and culture time, the different tested ions 
elicited different patterns of cell response, as already stated in previous works (J. Zhang  et 
al., 2003). Cerium, for instance, was shown to induce osteoclast differentiation, whereas, pra-
seodymium and lanthanum inhibited their differentiation, at least at the highest concentrations 
tested.   
In some cases, the results obtained also highlighted an opposite effect of the same cation 
depending on the cell type. This contrasting effect was observed, for example, in the cultures 
performed in the presence of praseodymium. This lanthanide was shown to regulate positively 
osteoblast density, while the opposite effect was observed on osteoclast cultures. 
The duality of the biological effects of lanthanides, observed in the present study, is con-
sidered one of the most common features of these elements (K. Wang et al., 2003). This dual 
behaviour may result, in part, from lanthanide ability to interfere with the intracellular calcium 
ionic concentration in a bidirectional way (Riccardi, Finney, Wilkinson, & Kemp, 2009). Moreo-
ver, the different physicochemical characteristics, such as, ionic radius and charge density, 
may be also responsible for this twofold effect (K. Wang et al., 1999). Lastly, the wide range 
of experimental models, culture conditions and evaluated parameters may also explain the 
contradictory results often found on literature reports. 
The broad biological activity spectrum and the two-sidedness effect identified in the pre-
sent study, reveal that lanthanides may have a potential to intervene in pathologic events 
characterized by an imbalance of the bone remodeling process, such as osteoporosis, Paget’s 
disease, and inflammatory conditions such as rheumatoid arthritis (Vidaud et al., 2012). In 
addition, lanthanides might be also relevant when considering the potential approaches for the 
development of biomaterials targeting bone tissue repair or regeneration (J. Coelho et al., 
2012). However, the clinical success of those applications will depend on the ability to find a 
balance between the differential effects that lanthanides have in different cell types. To ac-
complish this goal, further studies are required for the evaluation of lanthanides on bone cells 
activity, namely, the effect of lanthanides on the mineralized matrix formation, level of intra-
cellular calcium, calcium phosphate-resorbing ability and gene expression. Besides, further ex-
periments on the mechanisms of lanthanides affecting bone cell proliferation, apoptosis and 
differentiation should also be addressed in the future. 
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Chapter 5 
 
 
Conclusion and Future Directions 
 
 
 
5.1 Conclusion 
 
The biological properties of the lanthanides, primary based on their similarity to the cal-
cium, have been the basis for research into potential therapeutic applications of lanthanides 
since the early part of the twentieth century. This ability is of outermost importance, since 
calcium signals have been found to play a role in a wide range of cellular processes such as 
exocytosis, contraction, cell proliferation, differentiation and apoptosis. 
More recently, lanthanides have been shown to be able to modulate the behaviour of bone-
relevant cellular populations. Indeed, lanthanides ions exchange with calcium ions in bone, and 
modulate the remodeling cycle by acting on bone cells. This observation emphasised the pro-
spective use of lanthanides on therapeutic approaches designed for the treatment of pathologic 
events characterized by an unbalanced bone turnover and for the development of biomaterials 
targeting bone tissue repair or regeneration.  
Several works have already assessed the effect of these elements on bone cells activity, 
nonetheless, only a few reports evaluated these effect on human osteoblasts and osteoclasts. 
Moreover, the signalling pathways involved on the cellular response induced by lanthanides has 
not been elucidated so far. Therefore this study was set out to explore the cellular and molec-
ular effects of different lanthanides at different concentrations on human osteoblasts and os-
teoclast precursor cells cultured in vitro. Moreover, the involvement of some osteoblastogen-
esis- and osteoclastogenesis-related signalling pathways on cellular response were addressed. 
The results obtained confirmed the previous stated ability of lanthanides to modulate bone 
cells activity. In agreement with previous reports, it was often observed a relationship between 
the concentration/culture time and the biological effects attained by the lanthanides tested. 
The experiments conducted with human osteoblast precursor cells provided some insights 
about the influence of cerium, lanthanum and praseodymium in this cell type. Cerium did not 
affect osteoblast precursor cells proliferation, in opposition, enhanced cell differentiation at 
the lowest concentrations. Lanthanum exhibited an opposite effect on osteoblast precursor 
cells proliferation and differentiation at the two time points investigated. Praseodymium stim-
ulated osteoblast precursor cells proliferation at all the concentrations tested, yet, the same 
effect on differentiation was only observed at the lowest concentrations. 
 The experiments carried out on osteoclast precursor cell cultures showed, in some cases, 
contrasting effects to the observed on osteoblast precursor cells cultures. Cerium, for instance 
was shown to be able to modulate the density of osteoclast precursor cells, an effect that was 
not observed on osteoblast precursor cell cultures. Moreover, this cation increased osteoclast 
precursor cells density regardless of the concentration tested. Lanthanum was shown to mod-
ulate osteoclast precursor cells density, yet, this effect was only observed over time, highlight-
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ing the impact of culture time. The effect of lanthanum on osteoclast precursor cells differen-
tiation was also concentration-dependent. Praseodymium was shown to be able to down-regu-
lated both osteoclast density and differentiation. 
Due to the connexion between apoptosis and the cell cycle, the activity of caspase-3 was 
also assessed. Some interesting findings were identified. The apoptotic profile of osteoblast 
precursor cells culture in the presence of cerium and lanthanum was identical, however, the 
apoptotic response was shown to be pronounced when cells were cultured in the presence of 
cerium. Caspase-3 activity of osteoclast precursor cells was shown to be considerably inhibited 
by lanthanum and praseodymium. 
Regarding the involvement of some osteoblastogenesis- and osteoclastogenesis-related sig-
nalling pathways in the cellular response promoted by the lanthanides some important findings 
were made. NFkB pathway, for instance, was shown to be involved in the response of both 
osteoblast and osteoclast precursor cells cultured in the presence of lanthanides. Furthermore, 
JNK pathway was shown to be as important as NFkB pathway in the response of osteoblast 
precursor cells, nevertheless, the same significance was not identified on osteoclast precursor 
cells. 
All in all, this work provided new insights on the ability of lanthanides to modulate the 
development human bone cells and clarified the involvement of some signalling pathways on 
the cellular response induced by these elements. Lastly, this work underlined the dual behav-
iour of lanthanides and the importance of manage it in order to achieve different results in 
bone metabolism/regeneration. Although the results were promising, further experiments are 
required to understand the general influence of lanthanides on human bone cells activity and 
their mechanisms of action. 
 
 
5.2 Future Directions 
 
In the future, it would be important to determine the cytotoxic effect of lanthanides. In 
the present work, the assumptions regarding the potential toxicity of the elements tested, was 
supposed by means of the DNA content and the apoptotic response. Nevertheless, a more spe-
cific assay, such as, the lactate dehydrogenase (LDH) assay should be performed. In previous 
works, the cytotoxic effect of lanthanides on osteoblast was assessed using the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay, however, since this assay is 
based on mitochondrial activity of cells, is not the best option to evaluate the effect on osteo-
clast cultures. 
Moreover, the duration of the study may be expanded, so that we can evaluate the effect 
of lanthanides at long-term. In this study it was often observed an opposite behaviour profile 
between day 14 and 21, thus, it would be interesting to observe the evolution of this profile. 
Likewise, based on the obtained results, the concentration range could be narrowed using the 
one that induced the intended response in order to establish a more specific interval. 
Currently, it is well-stablished that osteoblasts not only play a central role in bone for-
mation, but also regulate osteoclasts. Moreover, osteoclast-osteoblast interactions have been 
shown to perform an important role coupling bone resorption and formation. Therefore, it 
would be interesting to assess the effect of lanthanides on co-cultures of osteoblasts and oste-
oclasts, and understand if the communication between this two cell types, enhances or not the 
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effects observed in the present study. Zhang et al. have already evaluated the effect of lan-
thanum on the bone resorbing activity of rabbit osteoclasts co-cultured with osteoblasts, and 
observed that direct cell-cell contact between osteoclasts and osteoblasts regulate the re-
sponse of osteoclasts to lanthanum(J. Zhang  et al., 2005).  
Additionally, it would be also relevant to evaluate the combined effect of the different 
lanthanides, to understand if the response attained by them is reinforced or not. 
This study was developed on monolayer cell cultures, which do not reproduce the complex 
and dynamic three-dimensional environment experienced by bone cells in vivo. This type of 
structures allow to recapitulate and control the main biophysical, biochemical, and biomechan-
ical cues that define the in vivo bone environment(Bouet, Marchat, Cruel, Malaval, & Vico, 
2015). That being said, it would be interesting to analyse the behaviour of bone cells cultured 
in these structures in the presence of lanthanides. 
As mentioned along this work, lanthanides have attracted much attention in the treatment 
of bone density disorders. Thus, in order to have a more accurate perspective of the effects of 
lanthanides on these disorders, it would be important to conduct in vivo experiments in animal 
models. 
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